???global.info.a_carregar???
Identification

Personal identification

Full name
Fernando José Magro Dias

Citation names

  • Fernando Magro

Author identifiers

Ciência ID
C616-293B-A303
ORCID iD
0000-0003-2634-9668
AuthenticusID
R-000-50A
Google Scholar ID
https://scholar.google.com.br/citations?user=A76HZQIAAAAJ&hl=pt-PT
Researcher Id
DXK-3709-2022
Scopus Author Id
55901273800

Knowledge fields

  • Medical and Health Sciences - Clinical Medicine - Gastroenterology and hepatology

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
English Intermediate (B1) Intermediate (B1) Intermediate (B1) Intermediate (B1)
Education
Degree Classification
2018/03/20
Concluded
Farmacologia e Toxicologia Experimentais e Clínicas (Título de Agregado)
Universidade do Porto Faculdade de Medicina, Portugal
2007/04/09
Concluded
Pharmacology (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
"Contribuição para o estudo do sistema monoaminergico na doença inflamatória intestinal e num modelo de colite transmural" (THESIS/DISSERTATION)
maioria
1989/07/31
Concluded
Medicina (Licenciatura)
Universidade do Porto Faculdade de Medicina, Portugal
15.2
Affiliation

Teaching in Higher Education

Category
Host institution
Employer
2016/01 - Current Invited Associate Professor (University Teacher) Universidade do Porto Faculdade de Medicina, Portugal
Universidade do Porto Faculdade de Medicina, Portugal
2014/01 - 2016 Associate Professor (University Teacher) Universidade do Porto Faculdade de Medicina, Portugal
2013/01 - 2014 Assistant Professor (University Teacher) Universidade do Porto Faculdade de Medicina, Portugal

Other Careers

Category
Host institution
Employer
2012/01 - Current Assistente graduado (Médica) Centro Hospitalar Universitário de São João, Portugal
Centro Hospitalar Universitário de São João, Portugal

Positions / Appointments

Category
Host institution
Employer
2018/01 - Current Organic Unit Director Centro Hospitalar Universitário de São João, Portugal
Centro Hospitalar Universitário de São João - Unidade de Farmacologia Clínica, Portugal

Others

Category
Host institution
Employer
2017/01 - Current Especialidade em Farmacologia Clínica Centro Hospitalar Universitário de São João, Portugal
1998 - Current Especialidade em Gastrenterologia Centro Hospitalar Universitário de São João, Portugal
Projects

Grant

Designation Funders
2023/07 - Current Assessing the translational potential of dipeptidyl peptidase 4 and microbiome as biomarkers of inflammatory bowel disease
GEDII Innovate Fellowship 2023
Co-Principal Investigator (Co-PI)
Grupo de Estudo da Doença Inflamatória Intestinal (GEDII), Portugal

Universidade do Porto Faculdade de Medicina, Portugal
Grupo de Estudo da Doença Inflamatória Intestinal (GEDII)
Ongoing
2023/07 - Current MILESTONE - Monitoring Inflammatory boweL disEase and reSponse To biOlogic therapy through ACE2/ACE balaNcE
GEDII Compass 2023 Fellowship
Co-Principal Investigator (Co-PI)
Universidade do Porto Faculdade de Farmácia, Portugal
Ongoing
2023/07 - Current PAthology features in Crohn’s DiseasE - PACE project
GEDII Compass 2023 Fellowship
Co-Principal Investigator (Co-PI)
Centro Hospitalar do Algarve EPE, Portugal

Algarve Biomedical Center Research Institute, Portugal
Ongoing
2019/01/02 - 2020/12/31 Up to date immunizations in Adults with Imune-Mediated Inflammatory Conditions
Pfizer grant ID 42420671
Laboratórios Pfizer Ltda
Ongoing

Contract

Designation Funders
2021/04 - Current 4WARD - Looking 4WARD: The role of dipeptidyl peptidase 4 (DPP-4) in inflammatory bowel disease (IBD) as a novel biomarker for predicting disease activity and monitoring response to therapy in IBD patients
4WARD
Principal investigator
Grupo de Estudo da Doença Inflamatória Intestinal (GEDII), Portugal
Ongoing
2020/10 - Current IBD(OME) - Gut microbiome and IBD therapy: an interplay?
IBD(OME)
Principal investigator
Grupo de Estudo da Doença Inflamatória Intestinal (GEDII), Portugal
Ongoing
2021/01/01 - 2025/12/31 Rede de Investigação em Saúde: do Laboratório à Saúde Comunitária
LA/P/0053/2020
Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Universidade do Algarve, Portugal

Universidade do Porto Faculdade de Ciências, Portugal

Universidade da Madeira, Portugal

Universidade Nova de Lisboa, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Universidade de Lisboa Centro Cardiovascular da Universidade de Lisboa, Portugal

Universidade de Aveiro, Portugal

Centro de Investigação em Tecnologias e Serviços de Saúde, Portugal

Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal

Escola Superior de Enfermagem do Porto, Portugal

Universidade do Porto Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2016/06/01 - 2020/03/01 Intervenção farmacológica sobre sensores e mecanismos de transporte iónico na fibrose da doença de Crohn
PTDC/DTP-FTO/0735/2014
Universidade do Porto Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2019/01/01 - 2019/12/31 Centro de Investigação Farmacológica e Inovação Medicamentosa
UID/BIM/04308/2019
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2014/04/02 - 2015/08/01 RES4MED:Aprender medicina através da investigação
EXPL/IVC-PEC/1302/2013
Universidade do Porto Faculdade de Medicina, Portugal

Universidade do Porto Centro de Farmacologia e Biopatologia Química, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2012/02/01 - 2015/04/30 Efeitos regulatórios exercidos pelos receptores envolvidos no reconhecimento de antigénios microbianos no transporte de eletrólitos e potencial de membrana em células epiteliais intestinais.
PTDC/SAU-TOX/117664/2010
Universidade do Porto Faculdade de Medicina, Portugal

Universidade do Porto Centro de Farmacologia e Biopatologia Química, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2011/01/01 - 2013/12/31 Projecto Estratégico - UI 38 - 2011-2012
PEst-OE/SAU/UI0038/2011
Universidade do Porto Centro de Farmacologia e Biopatologia Química, Portugal

Universidade do Porto Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2009/01/01 - 2012/06/30 Infecção micobacteriana e doença de Crohn.
PIC/IC/82802/2007
Instituto de Biologia Molecular e Celular, Portugal

Fundação Ensino e Cultura Fernando Pessoa, Portugal

Hospital de São João, Portugal
Fundação para a Ciência e a Tecnologia
Concluded

Other

Designation Funders
2021 - Current Iron deficiency anemia in inflammatory bowel disease. Correlation with inflammation and Vitamin D status
IRON
Researcher
Grupo de Estudo da Doença Inflamatória Intestinal (GEDII)
2021 - Current An epidemiological study to determine the prevalence of Microscopic Colitis and describe its clinical and histological features among patients with symptoms of chronic watery diarrhea submitted to colonoscopy Attending to the Portuguese gastroenterology setting: MICRA study
MICRA study
Principal investigator
2021 - Current BIOAZA: Impact of AZAthioprine in inducing and maintaining clinical, BI- Omarkers and endoscopic remission among patients with Crohn’s Disease: a 2-year longitudinal analysis from the GEDII Registry
BIOAZA
Principal investigator
2021 - Current Correlation between IFX serum levels and anti-TNF antibody therapy (ATIs) in different pharmacokinetics times and endoscopic healing (CISAE)
CISAE
Principal investigator
2021 - Current EASY - Early Surgery or Immunossupppression
EASY
Principal investigator
2020 - Current Validation of questionnaire for life satisfaction in Crohn’s disease patients (vision study)
N/A
Principal investigator
2017 - Current FORTIFY: A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991; or Completed M15-989
2016-003191-50
Coordenador nacional
2017 - Current MOTIVATE: A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Assess the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment
2016-003190-17
Coordenador nacional
2017 - Current ADVANCE: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severe Active Crohn’s Disease
2016-003123-32
Coordenador nacional
2017 - Current STARDUST: Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn’s Disease Patients Treated with Ustekinumab
2016-002918-43
Coordenador nacional
2016 - Current Study to investigate the correlation of fecal calprotectin with serum Drug levels and development of antI-dRug antibodiEs among adult patients with inflammatory bowel disease reCeiving anti-TNF-alfa treatment or Vedoluzimab treatment - Direct Study
DIRECT
Principal investigator
Grupo de Estudo da Doença Inflamatória Intestinal (GEDII)
Ongoing
2016 - Current A study in the real-world practice to evaluate the impact of biosimilar infliximab (Remsima) in clinical outcomes in patients with inflammatory bowel diseases: a 2-year longitudinal analysis from the GEDII Registry
REMREGISTER
Principal investigator
Universidade do Porto Faculdade de Medicina, Portugal
Grupo de Estudo da Doença Inflamatória Intestinal (GEDII)
Ongoing
2016 - Current A study in the real-world practice to evaluate the impact of biosimilar infliximab (Inflectra) in clinical outcomes in patients with inflammatory bowel diseases: a 2-year longitudinal analysis from the GEDII Registry
N/A
Principal investigator
2015 - Current Accuracy of calprotectin in evaluating sub-clinical inflammation in ulcerative colitis (ACERTIVE)
ACERTIVE
Principal investigator
Universidade do Porto Faculdade de Medicina, Portugal
Grupo de Estudo da Doença Inflamatória Intestinal (GEDII)
Concluded
2015 - Current EVOLUTION: An open label, single group assignment design study to correlate soluble ST2 with clinical, endoscopic and histological activity in moderate to severe Ulcerative Colitis patients under golimumab
2014–003262–25
Coordenador nacional
2015 - 2022 I-CARE: IBD, cancer and serious infections in Europe
I-CARE
2011 - 2021 OPERA study: PF-00547659 is Safe and Improves Disease Symptoms in Patients with Crohn's Disease
NCT01276509
Principal investigator
2008 - 2015 An Open Randomized Multicenter Clinical Investigation to Compare the Efficacy and Safety of Prednisone plus Adacolumn® GMA Apheresis versus Prednisone Alone in the Treatment of Patients with Mild or Moderately Active Steroid Dependent Ulcerative Colitis)
NCT00702611
Principal investigator
Outputs

Publications

Book
  1. Sarmento, A.; Campos, N.; Appelberg, R.; Magro, F.. Defective macrophage function in crohn's disease. 2012.
Book chapter
  1. Magro, F.; António, T.. "Fibrosis in ulcerative colitis". 147-157. 2018.
Conference abstract
  1. Isadora Rosa; Patrícia Silva; Sara Mata; Fernando Magro; Fatima Carneiro; Armando Peixoto; Marco Silva; et al. "Mo1868 ¿ Methylation Patterns in Dysplasia in Inflammatory Bowel Disease Patients". 2019.
    10.1016/s0016-5085(19)39135-8
Conference paper
  1. Dias, C.C.; Magro, F.; Rodrigues, P.P.. "Disabling and reoperation in patients with Crohn's disease subject to early surgery or immunosuppression: A Bayesian network prognostic model". 2016.
    10.1109/CBMS.2016.65
  2. Dias, C.C.; Magro, F.; Rodrigues, P.P.. "Preliminary study for a bayesian network prognostic model for Crohn's Disease". 2015.
    10.1109/CBMS.2015.40
Conference poster
  1. Ferreira-Duarte, Mariana; Lilian Caroline Gonçalves Oliveira; Dulce Elena Casarini; Esteves-Monteiro, Marisa; Quintas, Clara; Sousa, Teresa; Duarte-Araújo, Margarida; Fernando Magro; Manuela Morato. "Fecal ACE and ACE2 activities in patients with Inflammatory Bowel Disease on biological treatment". Paper presented in Gordon Research Conference - Interplay between the RAAS and other hormonal systems, 2024.
  2. Mariana Ferreira-Duarte; Tiago Rodrigues-Pinto; Fernando Magro; Margarida Duarte-Araújo; Manuela Morato. "Neural and non-neural cells play a role in angiotensin II-mediated colonic contraction in the rat model of inflammatory bowel disease.". Paper presented in Grupo de Estudo da Doença Inflamatória Intestinal (GEDII) Annual Meeting, Porto, Portugal., 2021.
  3. Sarmento, A. ; Cabeda, JM; Santiago M; Duro M; Pita I; Morais, R.; Macedo, Guilherme; Bull, Tim J.; Fernando Magro. "Patients with Crohn's disease or liver cirrhosis show increased frequency of viable Mycobacterium avium subsp. paratuberculosis". Paper presented in European Society of Mycobacteriology 2021 Virtual Congress, 2021.
  4. Mariana Ferreira-Duarte; Fernando Magro; Margarida Duarte-Araújo; Manuela Morato. "Angiotensin II-mediated contraction of the colon: a role for different mediators in an experimental model of inflammatory bowel disease". Paper presented in Gordon Research Seminar: Angiotensin Beyond Hypertension: Existing and Novel Therapies, Lucca, Italy., 2020.
  5. Mariana Ferreira-Duarte; Fernando Magro; Margarida Duarte-Araújo; Manuela Morato. "Role for neural and non-neural cells in Angiotensin II-mediated contraction of the colon: a study with the rat TNBS-induced model of inflammatory bowel disease.". Paper presented in Gordon Research Conference - The RAAS: Integrating Novel Technologies, Clinical Studies and Personalized Therapeutics to Preserve Health, Lucca, Italy., 2020.
  6. Mariana Leite-Silva; Mariana Ferreira-Duarte; Fernando Magro; Margarida Duarte-Araújo; Manuela Morato. "Reactivity to angiotensin II in the proximal colon of rats with experimental inflammatory bowel disease". Paper presented in IJUP 2019, February 2019, Porto, Portugal, 2019.
  7. Assunção, Amélia; Nair Nazareth; Fernando Magro; Jani Silva; Mary Duro; Daniela Gracio; Rui Coelho; Rui Appelberg; Guilherme Macedo. "Infliximab-dependent improvement of the TNF response to bacteria depends on enrichment of circulating CD16+ monocytes". Paper presented in 10th Congress of ECCO 2015, 2015.
Journal article
  1. Sousa, Paula; Magro, Fernando. "Author's Reply: “Immunomodulator combination versus mono therapy: Does combination therapy have an impact on infliximab therapy?”". Digestive and Liver Disease 56 3 (2024): 532-533. http://dx.doi.org/10.1016/j.dld.2023.12.006.
    10.1016/j.dld.2023.12.006
  2. Solitano, Virginia; Facheris, Paola; Petersen, Magnus; D'Amico, Ferdinando; Ortoncelli, Michela; Aletaha, Daniel; Olivera, Pablo A.; et al. "Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study". Autoimmunity Reviews 23 3 (2024): 103504. http://dx.doi.org/10.1016/j.autrev.2023.103504.
    10.1016/j.autrev.2023.103504
  3. Fantini, Massimo Claudio; Fiorino, Gionata; Colli, Agostino; Laharie, David; Armuzzi, Alessandro; Caprioli, Flavio Andrea; Gisbert, Javier P; et al. "Pragmatic trial design to compare real-world effectiveness of different treatments for inflammatory bowel diseases: the PRACTICE-IBD European consensus". Journal of Crohn's and Colitis (2024): http://dx.doi.org/10.1093/ecco-jcc/jjae026.
    10.1093/ecco-jcc/jjae026
  4. Fernando Magro; Maria Manuela Estevinho; André Valois. "Managing Ulcerative Colitis and Crohn’s Disease: Should the Target Be Endoscopy, Histology, or Both?". Journal of the Canadian Association of Gastroenterology (2024): https://doi.org/10.1093/jcag/gwad034.
    10.1093/jcag/gwad034
  5. Fernando Magro; Samuel Fernandes; Marta Patita; Bruno Arroja; Paula Lago; Isadora Rosa; Helena Tavares de Sousa; et al. "The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients". Journal of Crohn's and Colitis (2024): https://doi.org/10.1093/ecco-jcc/jjae014.
    10.1093/ecco-jcc/jjae014
  6. Laurent Peyrin-Biroulet; Séverine Vermeire; Geert D'Haens; Julian Panés; Axel Dignass; Fernando Magro; Maciej Nazar; et al. "Clinical trial: Clinical and endoscopic outcomes with ustekinumab in patients with Crohn's disease: Results from the long-term extension period of STARDUST". Alimentary Pharmacology & Therapeutics (2024): https://doi.org/10.1111/apt.17751.
    10.1111/apt.17751
  7. Ferreira-Duarte, Mariana; Lilian Caroline Gonçalves Oliveira; Clara Quintas; Dias-Pereira, Patrícia; Teresa Sousa; Fernando Magro; Dulce Elena Casarini; Duarte-Araújo, Margarida; Manuela Morato. "Angiotensin-converting enzymes 1 and 2 in the feces: presence and catalytical activity in the rat TNBS-induced model of colitis". Journal of Gastroenterology & Hepathology (2024):
    Under revision
  8. Ferreira-Duarte, Mariana; Clara Quintas; Bom, Joana; Ana Lúcia Ribeiro; Marília Pereira; Michael Bader; Natalia Alenina; et al. "ACE and ACE2 in the feces - an interplay between intestinal shedding and the microbiota". Journal of Physiology and Biochemistry (2024):
    Under revision
  9. Samuel Raimundo Fernandes; Sónia Bernardo; Sofia Saraiva; Ana Rita Gonçalves; Paula Moura Santos; Ana Valente; Luís Araújo Correia; Helena Cortez-Pinto; Fernando Magro. "Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease". United European Gastroenterology Journal (2023): https://doi.org/10.1002/ueg2.12497.
    10.1002/ueg2.12497
  10. Samuel Raimundo Fernandes; Sónia Bernardo; Sofia Saraiva; Ana Rita Gonçalves; Paula Moura Santos; Ana Valente; Luís Araújo Correia; Helena Cortez-Pinto; Fernando Magro. "Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn’s Disease: A Propensity Score–Matched Analysis". Inflammatory Bowel Diseases (2023): https://doi.org/10.1093/ibd/izad272.
    10.1093/ibd/izad272
  11. Magro, Fernando; Protic, Marijana; De Hertogh, Gert; Chan, Lai Shan; Pollack, Paul; Jairath, Vipul; Carlier, Hilde; et al. "Effects of Mirikizumab on Histologic Resolution of Crohn's Disease in a Randomized Controlled Phase 2 Trial". Clinical Gastroenterology and Hepatology (2023): http://dx.doi.org/10.1016/j.cgh.2023.11.010.
    10.1016/j.cgh.2023.11.010
  12. Sousa, Paula; Patita, Marta; Arroja, Bruno; Lago, Paula; Rosa, Isadora; de Sousa, Helena Tavares; Ministro, Paula; et al. "Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab". Digestive and Liver Disease (2023): http://dx.doi.org/10.1016/j.dld.2023.10.027.
    10.1016/j.dld.2023.10.027
  13. Fernando Magro; Rish K Pai; Taku Kobayashi; Vipul Jairath; Florian Rieder; Isabel Redondo; Trevor Lissoos; et al. "Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes". Journal of Crohn's and Colitis (2023): https://doi.org/10.1093/ecco-jcc/jjad050.
    10.1093/ecco-jcc/jjad050
  14. D’Amico, Ferdinando; Solitano, Virginia; Magro, Fernando; Olivera, Pablo A.; Halfvarson, Jonas; Rubin, David; Dignass, Axel; et al. "Practical Management of Biosimilar Use in Inflammatory Bowel Disease (IBD): A Global Survey and an International Delphi Consensus". Journal of Clinical Medicine 12 19 (2023): 6350. http://dx.doi.org/10.3390/jcm12196350.
    10.3390/jcm12196350
  15. Fernando Magro; Maria Manuela Estevinho. "Reporting of endoscopy and histology of ulcerative colitis in routine clinical practice: How far we are!". United European Gastroenterology Journal (2023): https://doi.org/10.1002/ueg2.12432.
    10.1002/ueg2.12432
  16. Borella, Matteo; Baghdadi, Ali; Bertoldo, Giovanni; Della Lucia, Maria Cristina; Chiodi, Claudia; Celletti, Silvia; Deb, Saptarathi; et al. "Transcriptomic and physiological approaches to decipher cold stress mitigation exerted by brown-seaweed extract application in tomato". Frontiers in Plant Science 14 (2023): http://dx.doi.org/10.3389/fpls.2023.1232421.
    10.3389/fpls.2023.1232421
  17. Marcello Imbrizi; Fernando Magro; Claudio Saddy Rodrigues Coy. "Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years". Pharmaceuticals (2023): https://doi.org/10.3390/ph16091272.
    10.3390/ph16091272
  18. Wils, Pauline; Jairath, Vipul; Sands, Bruce E.; Magro, Fernando; Reinisch, Walter; Rubin, David; Danese, Silvio; Baumann, Cédric; Peyrin-Biroulet, Laurent. "Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease". United European Gastroenterology Journal 11 8 (2023): 797-806. http://dx.doi.org/10.1002/ueg2.12455.
    10.1002/ueg2.12455
  19. Couto, Mafalda; Andrade, Nelson; Magro, Fernando; Martel, Fátima. "Taurocholate uptake by Caco-2 cells is inhibited by pro-inflammatory cytokines and butyrate". Cytokine 169 (2023): 156307. http://dx.doi.org/10.1016/j.cyto.2023.156307.
    10.1016/j.cyto.2023.156307
  20. Parigi, Tommaso Lorenzo; D'Amico, Ferdinando; Abreu, Maria T; Dignass, Axel; Dotan, Iris; Magro, Fernando; Griffiths, Anne M; et al. "Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting". The Lancet Gastroenterology & Hepatology 8 9 (2023): 853-859. http://dx.doi.org/10.1016/s2468-1253(23)00154-1.
    10.1016/s2468-1253(23)00154-1
  21. Feakins, Roger; Borralho Nunes, Paula; Driessen, Ann; Gordon, Ilyssa O; Zidar, Nina; Baldin, Pamela; Christensen, Britt; et al. "Definitions of Histological Abnormalities in Inflammatory Bowel Disease: an ECCO Position Paper". Journal of Crohn's and Colitis (2023): http://dx.doi.org/10.1093/ecco-jcc/jjad142.
    10.1093/ecco-jcc/jjad142
  22. Schreiber, Stefan; Danese, Silvio; Dignass, Axel; Domènech, Eugeni; Fantini, Massimo C; Ferrante, Marc; Halfvarson, Jonas; et al. "Defining Comprehensive Disease Control for Use as a Treatment Target for Ulcerative Colitis in Clinical Practice: International Delphi Consensus Recommendations". Journal of Crohn's and Colitis 18 1 (2023): 91-105. http://dx.doi.org/10.1093/ecco-jcc/jjad130.
    10.1093/ecco-jcc/jjad130
  23. D’Amico, Ferdinando; Magro, Fernando; Siegmund, Britta; Kobayashi, Taku; Kotze, Paulo Gustavo; Solitano, Virginia; Caron, Benedicte; et al. "Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus". Inflammatory Bowel Diseases (2023): http://dx.doi.org/10.1093/ibd/izad159.
    10.1093/ibd/izad159
  24. Joana Roseira; Mafalda Santiago; Maria Manuela Estevinho; Paula Moreira; Catarina Alves; Silvio Danese; Laurent Peyrin-Biroulet; et al. "Impact of Crohn’s Disease Therapies on Histology in Randomized Controlled Trials: Systematic Review With Meta-analysis". Inflammatory Bowel Diseases (2023): https://doi.org/10.1093/ibd/izac203.
    10.1093/ibd/izac203
  25. Couto, Mafalda R.; Andrade, Nelson; Magro, Fernando; Martel, Fátima. "Bile salts and proinflammatory cytokines inhibit MCT1-mediated cellular uptake of butyrate and interfere with its antiproliferative properties". Experimental Cell Research 429 2 (2023): 113670. http://dx.doi.org/10.1016/j.yexcr.2023.113670.
    10.1016/j.yexcr.2023.113670
  26. Magro, Fernando; Estevinho, Maria Manuela. "Reporting of endoscopy and histology of ulcerative colitis in routine clinical practice: How far we are!". United European Gastroenterology Journal 11 8 (2023): 720-721. http://dx.doi.org/10.1002/ueg2.12432.
    10.1002/ueg2.12432
  27. Maria Manuela Estevinho; Fernando Magro. "Editorial: elderly onset inflammatory bowel disease - clues from the largest population-based cohort study". Alimentary Pharmacology & Therapeutics (2023): https://doi.org/10.1111/apt.17543.
    10.1111/apt.17543
  28. Fernando Magro; Maria Manuela Estevinho; Gaia Catalano; Marta Patita; Bruno Arroja; Paula Lago; Isadora Rosa; et al. "How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?—A prospective study". United European Gastroenterology Journal (2023): https://doi.org/10.1002/ueg2.12420.
    10.1002/ueg2.12420
  29. Helena Tavares de Sousa; Fernando Magro. "How to Evaluate Fibrosis in IBD?". Diagnostics (2023): https://doi.org/10.3390/diagnostics13132188.
    10.3390/diagnostics13132188
  30. Tavares de Sousa, Helena; Magro, Fernando. "How to Evaluate Fibrosis in IBD?". Diagnostics 13 13 (2023): 2188. http://dx.doi.org/10.3390/diagnostics13132188.
    10.3390/diagnostics13132188
  31. Magro, Fernando; Estevinho, Maria Manuela; Catalano, Gaia; Patita, Marta; Arroja, Bruno; Lago, Paula; Rosa, Isadora; et al. "How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?—A prospective study". United European Gastroenterology Journal 11 6 (2023): 531-541. http://dx.doi.org/10.1002/ueg2.12420.
    10.1002/ueg2.12420
  32. Estevinho, Maria Manuela; Magro, Fernando. "Editorial: elderly onset inflammatory bowel disease - clues from the largest population-based cohort study". Alimentary Pharmacology & Therapeutics 58 1 (2023): 116-117. http://dx.doi.org/10.1111/apt.17543.
    10.1111/apt.17543
  33. Estevinho, Maria Manuela; Cabeda, José; Santiago, Mafalda; Machado, Elisabete; Silva, Ricardo; Duro, Mary; Pita, Inês; et al. "Viable Mycobacterium avium subsp. paratuberculosis Colonizes Peripheral Blood of Inflammatory Bowel Disease Patients". Microorganisms 11 6 (2023): 1520. http://dx.doi.org/10.3390/microorganisms11061520.
    10.3390/microorganisms11061520
  34. Abreu, Cândida; Martins, António; Branco, Elsa; Rocha, Rafael; Sarmento, António; Magro, Fernando. "Vaccines – beliefs and concerns: the voice of patients with inflammatory immunomediated diseases". European Journal of Gastroenterology & Hepatology 35 8 (2023): 848-853. http://dx.doi.org/10.1097/meg.0000000000002589.
    10.1097/meg.0000000000002589
  35. Maria Manuela Estevinho; Cabeda, JM; Mafalda Santiago; Elisabete Machado; Ricardo Silva; Mary Duro; Inês Pita; et al. "Viable Mycobacterium avium subsp. paratuberculosis Colonizes Peripheral Blood of Inflammatory Bowel Disease Patients". Microorganisms (2023): https://www.mdpi.com/2076-2607/11/6/1520.
    10.3390/microorganisms11061520
  36. Panés, Julian; Vermeire, Séverine; D'Haens, Geert R.; Danese, Silvio; Magro, Fernando; Nazar, Maciej; Le Bars, Manuela; et al. "Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: Results up to Week 104 of the STARDUST trial". United European Gastroenterology Journal 11 5 (2023): 410-422. http://dx.doi.org/10.1002/ueg2.12384.
    10.1002/ueg2.12384
  37. Dina Cosme; Patrício Soares-da-Silva; Fernando Magro. "Long-term effect of Toll-like receptor-2, -4, -5, -7 and NOD2 stimulation on Na+,K+-ATPase activity and expression in intestinal epithelial cells". American Journal of Physiology-Cell Physiology (2023): https://doi.org/10.1152/ajpcell.00208.2022.
    10.1152/ajpcell.00208.2022
  38. Helena Tavares de Sousa; Irene Gullo; Fernando Magro. "Fibromuscular Expansion in Crohn’s Disease Ileal Strictures: An Open Issue". Clinical Gastroenterology and Hepatology (2023): https://doi.org/10.1016/j.cgh.2022.06.023.
    10.1016/j.cgh.2022.06.023
  39. Gomes, Sandra F.; Melo, Francisco Jorge; Silva, Rita; Santiago, Mafalda; Estevinho, Maria Manuela; Dias, Sandra; Dias, Cláudia Camila; Magro, Fernando. "Dipeptidyl peptidase 4 (DPP4) in fecal samples: validation of the extraction methodology and stability in short-term storage conditions". Clinical Chemistry and Laboratory Medicine (CCLM) 61 9 (2023): 1636-1642. http://dx.doi.org/10.1515/cclm-2023-0139.
    10.1515/cclm-2023-0139
  40. Magro, Fernando; Pai, Rish K; Kobayashi, Taku; Jairath, Vipul; Rieder, Florian; Redondo, Isabel; Lissoos, Trevor; et al. "Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes". Journal of Crohn's and Colitis 17 9 (2023): 1457-1470. http://dx.doi.org/10.1093/ecco-jcc/jjad050.
    10.1093/ecco-jcc/jjad050
  41. Candida Abreu; Antonio Martins; Fernando Silva; Gabriela Canelas; Lucia Ribeiro; Stefano Pinto; Antonio Sarmento; Fernando Magro. "Adherence to Vaccines in Adult Patients with Immune-Mediated Inflammatory Diseases: A Two-Year Prospective Portuguese Cohort Study". Vaccines (2023): https://doi.org/10.3390/vaccines11030703.
    10.3390/vaccines11030703
  42. Pablo A Olivera; Juan S Lasa; Ignacio Zubiaurre; Vipul Jairath; Maria T Abreu; David T Rubin; Walter Reinisch; et al. "Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials". Journal of Crohn's and Colitis (2023): https://doi.org/10.1093/ecco-jcc/jjac133.
    10.1093/ecco-jcc/jjac133
  43. Fernando Magro; Paula Leão Moreira; Gaia Catalano; Catarina Alves; Joana Roseira; Maria Manuela Estevinho; Isabel Silva; et al. "Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta-analysis". United European Gastroenterology Journal (2023): https://doi.org/10.1002/ueg2.12366.
    10.1002/ueg2.12366
  44. Jae Hee Cheon; Kristine Paridaens; Sameer Al Awadhi; Jakob Begun; John R Fullarton; Edouard Louis; Fernando Magro; et al. "The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis". Intestinal Research (2023): https://doi.org/10.5217/ir.2022.00006.
    10.5217/ir.2022.00006
  45. Bénédicte Caron; Vipul Jairath; Ferdinando D’Amico; Sameer Al Awadhi; Axel Dignass; Ailsa L. Hart; Taku Kobayashi; et al. "International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients". Medicina (2023): https://doi.org/10.3390/medicina59010183.
    10.3390/medicina59010183
  46. Marla C Dubinsky; Fernando Magro; Flavio Steinwurz; David P Hudesman; Jami A Kinnucan; Ryan C Ungaro; Markus F Neurath; et al. "Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program". Inflammatory Bowel Diseases (2023): https://doi.org/10.1093/ibd/izac061.
    10.1093/ibd/izac061
  47. Diogo Magalhaes; Laurent Peyrin-Biroulet; Maria Manuela Estevinho; Silvio Danese; Fernando Magro. "Pursuing neutrophils: systematic scoping review on blood-based biomarkers as predictors of treatment outcomes in inflammatory bowel disease". Therapeutic Advances in Gastroenterology (2023): https://doi.org/10.1177/17562848231155987.
    10.1177/17562848231155987
  48. Ren Mao; Fernando Magro. "Changing paradigms in management of inflammatory bowel disease". United European Gastroenterology Journal (2022): https://doi.org/10.1002/ueg2.12347.
    10.1002/ueg2.12347
  49. Dina Cosme; Patrício Soares-da-Silva; Fernando Magro. "Effect of Toll-like receptor-2, -4, -5, -7, and NOD2 stimulation on potassium channel conductance in intestinal epithelial cells". American Journal of Physiology-Gastrointestinal and Liver Physiology (2022): https://doi.org/10.1152/ajpgi.00139.2022.
    10.1152/ajpgi.00139.2022
  50. Bénédicte Caron; Vipul Jairath; Ferdinando D’Amico; Kristine Paridaens; Fernando Magro; Silvio Danese; Laurent Peyrin-Biroulet. "Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review". United European Gastroenterology Journal (2022): https://doi.org/10.1002/ueg2.12283.
    10.1002/ueg2.12283
  51. Fernando Magro; Maria Manuela Estevinho. "COVID-19 Vaccines in IBD Patients: Particularities and Future Perspectives". Journal of Crohn's and Colitis (2022): https://doi.org/10.1093/ecco-jcc/jjac042.
    10.1093/ecco-jcc/jjac042
  52. Ferdinando D’Amico; Gionata Fiorino; Virginia Solitano; Eugenia Massarini; Lucas Guillo; Mariangela Allocca; Federica Furfaro; et al. "Ulcerative colitis: Impact of early disease clearance on long-term outcomes - A multicenter cohort study". United European Gastroenterology Journal (2022): https://doi.org/10.1002/ueg2.12288.
    10.1002/ueg2.12288
  53. F Magro; J Sabino; F Rosini; M Tripathi; P Borralho; P Baldin; S Danese; et al. "ECCO Position on Harmonisation of Crohn’s Disease Mucosal Histopathology". Journal of Crohn's and Colitis (2022): https://doi.org/10.1093/ecco-jcc/jjac006.
    10.1093/ecco-jcc/jjac006
  54. Alexander G. Meining; Fernando Magro; Joost P. H. Drenth. "UEG journal: The voice of European Gastroenterology". United European Gastroenterology Journal (2022): https://doi.org/10.1002/ueg2.12264.
    10.1002/ueg2.12264
  55. Mafalda Santiago; Cláudia Camila Dias; Catarina Alves; Paula Ministro; Raquel Gonçalves; Diana Carvalho; Francisco Portela; et al. "The Magnitude of Crohn’s Disease Direct Costs in Health Care Systems (from Different Perspectives): A Systematic Review". Inflammatory Bowel Diseases (2022): https://doi.org/10.1093/ibd/izab334.
    10.1093/ibd/izab334
  56. Fernando Magro; Catarina Alves; Mafalda Santiago; Paula Ministro; Paula Lago; Luís Correia; Raquel Gonçalves; et al. "Composite outcomes in observational studies of ulcerative colitis: A systematic review and meta-analysis". United European Gastroenterology Journal (2022): https://doi.org/10.1002/ueg2.12183.
    10.1002/ueg2.12183
  57. Maria Manuela Estevinho; Paula Leão Moreira; Isabel Silva; João Laranjeira Correia; Mafalda Santiago; Fernando Magro. "A scoping review on early inflammatory bowel disease: definitions, pathogenesis, and impact on clinical outcomes". Therapeutic Advances in Gastroenterology (2022): https://doi.org/10.1177/17562848221142673.
    10.1177/17562848221142673
  58. Fernando Magro; Catarina Sottomayor; Catarina Alves; Mafalda Santiago; Paula Ministro; Paula Lago; Luís Correia; et al. "Composite outcomes in observational studies of Crohn’s disease: a systematic review and meta-analysis". Therapeutic Advances in Gastroenterology (2022): https://doi.org/10.1177/17562848221092754.
    10.1177/17562848221092754
  59. Fernando Magro; Diogo Magalhães; Marta Patita; Bruno Arroja; Paula Lago; Isadora Rosa; Helena Tavares de Sousa; et al. "Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 Years". Clinical Gastroenterology and Hepatology (2021): https://doi.org/10.1016/j.cgh.2021.12.004.
    10.1016/j.cgh.2021.12.004
  60. Fernando Magro; Maria Manuela Estevinho; Roger Feakins. "Inflammation of the appendix in ulcerative colitis – Does it have a predictive value?". United European Gastroenterology Journal (2021): https://doi.org/10.1002/ueg2.12181.
    10.1002/ueg2.12181
  61. Ferdinando D’Amico; Fernando Magro; Laurent Peyrin-Biroulet; Silvio Danese. "Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis". Journal of Crohn's and Colitis (2021): https://doi.org/10.1093/ecco-jcc/jjab206.
    10.1093/ecco-jcc/jjab206
  62. Fernando Magro; Alexandre Nuzzo; Cândida Abreu; Diogo Libânio; Iago Rodriguez-Lago; Katarzyna Pawlak; Marcus Hollenbach; Willem P. Brouwer; Keith Siau. "COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology". United European Gastroenterology Journal 9 7 (2021): 750-765. https://doi.org/10.1002/ueg2.12115.
    10.1002/ueg2.12115
  63. Maria Manuela Estevinho; Fernando Magro. "Epithelial neutrophilic infiltrate - the rising star in ulcerative colitis". Clinical Gastroenterology and Hepatology (2021): https://doi.org/10.1016/j.cgh.2021.08.003.
    10.1016/j.cgh.2021.08.003
  64. Ferdinando D'Amico; David T. Rubin; Paulo Gustavo Kotze; Fernando Magro; Britta Siegmund; Taku Kobayashi; Pablo A. Olivera; et al. "International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases". United European Gastroenterology Journal 9 4 (2021): 451-460. https://doi.org/10.1002/ueg2.12069.
    10.1002/ueg2.12069
  65. Mariana Ferreira-Duarte; Tiago Rodrigues-Pinto; Teresa Sousa; Miguel A. Faria; Maria Sofia Rocha; Daniela Menezes-Pinto; Marisa Esteves-Monteiro; et al. "Interaction between the Renin–Angiotensin System and Enteric Neurotransmission Contributes to Colonic Dysmotility in the TNBS-Induced Model of Colitis". International Journal of Molecular Sciences 22 9 (2021): 4836-4836. https://doi.org/10.3390/ijms22094836.
    10.3390/ijms22094836
  66. Miehlke, Stephan; Guagnozzi, Danila; Zabana, Yamile; Tontini, Gian E.; Kanstrup Fiehn, Anne-Marie; Wildt, Signe; Bohr, Johan; et al. "European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations". United European Gastroenterology Journal 9 1 (2021): 13-37. http://dx.doi.org/10.1177/2050640620951905.
    10.1177/2050640620951905
  67. Roseira, Joana; Sousa, Helena T.; Marreiros, Ana; Contente, Luís F.; Magro, Fernando. "Short Inflammatory Bowel Disease Questionnaire: translation and validation to the Portuguese language". Health and Quality of Life Outcomes 19 1 (2021): http://dx.doi.org/10.1186/s12955-021-01698-9.
    10.1186/s12955-021-01698-9
  68. Ministro, Paula; Dias, Cláudia Camila; Portela, Francisco; Fernandes, Samuel; Bernardo, Sónia; Pires, Francisco; Lago, Paula; et al. "Age at Diagnosis Is Determinant for the Outcome of Inflammatory Bowel Disease: Is It a Myth?". Clinical and Translational Gastroenterology 12 2 (2021): e00309. http://dx.doi.org/10.14309/ctg.0000000000000309.
    10.14309/ctg.0000000000000309
  69. Fiorino, Gionata; Estevinho, Maria Manuela; Lopes, Diogo José M.; Chersi, Filippo; Allocca, Mariangela; Souto, Miguel Torre; Danese, Silvio; Magro, Fernando. "Inflammatory Bowel Disease in Migrant Populations: Should we look Even Further Back?". Current Drug Targets 22 (2021): http://dx.doi.org/10.2174/1389450122666210203193817.
    10.2174/1389450122666210203193817
  70. Siegel, Corey A; Melmed, Gil Y; McGovern, Dermot PB; Rai, Victoria; Krammer, Florian; Rubin, David T; Abreu, Maria T; Dubinsky, Marla C. "SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting". Gut 70 4 (2021): 635-640. http://dx.doi.org/10.1136/gutjnl-2020-324000.
    10.1136/gutjnl-2020-324000
  71. Rodrigo Borrega; Carlos Araújo; Nádia Aguiam; Fernando Magro; João Eurico Fonseca; Silvio Danese; João Lopes; Joao Goncalves. "Systematic Review and Principal Components Analysis of the Immunogenicity of Adalimumab". BioDrugs (2021): https://doi.org/10.1007/s40259-020-00458-3.
    10.1007/s40259-020-00458-3
  72. FERREIRA-DUARTE, Mariana; RODRIGUES-PINTO, Tiago; MENEZES-PINTO, Daniela; ESTEVES-MONTEIRO, Marisa; GONÇALVES-MONTEIRO, Salomé; CAPAS-PENEDA, Sara; MAGRO, Fernando; et al. "2,4,6-trinitrobenzenesulfonic acid-induced colitis in Rattus norgevicus: a categorization proposal". Experimental Animals (2021): http://dx.doi.org/10.1538/expanim.20-0113.
    10.1538/expanim.20-0113
  73. Olivera, P.A.; Zuily, S.; Kotze, P.G.; Regnault, V.; Al Awadhi, S.; Bossuyt, P.; Gearry, R.B.; et al. "International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease". Nature Reviews Gastroenterology and Hepatology 18 12 (2021): 857-873. http://www.scopus.com/inward/record.url?eid=2-s2.0-85113729718&partnerID=MN8TOARS.
    10.1038/s41575-021-00492-8
  74. Sousa, P.; Ministro, P.; Armuzzi, A.; Dignass, A.; Høivik, M.L.; Barreiro-de Acosta, M.; Vavricka, S.; et al. "Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel disease". Digestive and Liver Disease 53 12 (2021): 1571-1579. http://www.scopus.com/inward/record.url?eid=2-s2.0-85108829453&partnerID=MN8TOARS.
    10.1016/j.dld.2021.05.038
  75. Ungar, B.; Malickova, K.; Hanel, J.; Abu Arisha, M.; Paul, S.; Rocha, C.; Ben Shatach, Z.; et al. "Dose optimisation for Loss of Response to Vedolizumab - Pharmacokinetics and Immune Mechanisms". Journal of Crohn's and Colitis 15 10 (2021): 1707-1719. http://www.scopus.com/inward/record.url?eid=2-s2.0-85117915313&partnerID=MN8TOARS.
    10.1093/ecco-jcc/jjab067
  76. Albshesh, A.; Taylor, J.; Savarino, E.V.; Truyens, M.; Armuzzi, A.; Ribaldone, D.G.; Shitrit, A.B.-G.; et al. "Effectiveness of third-class biologic treatment in crohn’s disease: A multi-center retrospective cohort study". Journal of Clinical Medicine 10 13 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85114078800&partnerID=MN8TOARS.
    10.3390/jcm10132914
  77. Tavares de Sousa, H.; Gullo, I.; Castelli, C.; Dias, C.C.; Rieder, F.; Carneiro, F.; Magro, F.. "Ileal Crohn's Disease Exhibits Similar Transmural Fibrosis Irrespective of Phenotype". Clinical and translational gastroenterology 12 4 (2021): e00330-e00330. http://www.scopus.com/inward/record.url?eid=2-s2.0-85104338012&partnerID=MN8TOARS.
    10.14309/ctg.0000000000000330
  78. Charbit-Henrion, F.; Parlato, M.; Hanein, S.; Duclaux-Loras, R.; Nowak, J.; Begue, B.; Rakotobe, S.; et al. "Erratum: Diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: A multicenter study (Journal of Crohn's and Colitis DOI: 10.1093/ecco-jcc/jjy068)". Journal of Crohn's and Colitis 15 3 (2021): 517-518. http://www.scopus.com/inward/record.url?eid=2-s2.0-85103473930&partnerID=MN8TOARS.
    10.1093/ecco-jcc/jjaa164
  79. D'Amico, F.; Solitano, V.; Aletaha, D.; Hart, A.; Magro, F.; Selmi, C.; Ng, S.C.; et al. "Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensus". Autoimmunity Reviews 20 7 (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85108021085&partnerID=MN8TOARS.
    10.1016/j.autrev.2021.102849
  80. Dignass, A.U.; Paridaens, K.; Al Awadhi, S.; Begun, J.; Cheon, J.H.; Fullarton, J.R.; Louis, E.; et al. "Multinational evaluation of clinical decision-making in the treatment and management of mild-to-moderate ulcerative colitis". Scandinavian Journal of Gastroenterology (2021): http://www.scopus.com/inward/record.url?eid=2-s2.0-85121678367&partnerID=MN8TOARS.
    10.1080/00365521.2021.2015801
  81. Pinto-Lopes, P.; Melo, F.; Afonso, J.; Pinto-Lopes, R.; Rocha, C.; Melo, D.; Macedo, G.; et al. "Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease". Clinical and translational gastroenterology 12 3 (2021): e00320-e00320. http://www.scopus.com/inward/record.url?eid=2-s2.0-85102822027&partnerID=MN8TOARS.
    10.14309/ctg.0000000000000320
  82. Kucharzik, T.; Ellul, P.; Greuter, T.; Rahier, J.F.; Verstockt, B.; Abreu, C.; Albuquerque, A.; et al. "ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease". Journal of Crohn's and Colitis 15 6 (2021): 879-913. http://www.scopus.com/inward/record.url?eid=2-s2.0-85107338775&partnerID=MN8TOARS.
    10.1093/ecco-jcc/jjab052
  83. Dubinsky, M.C.; Collins, R.; Abreu, M.T.; Jairath, V.; Lewis, J.D.; Lindsay, J.; Merad, M.; et al. "Challenges and Opportunities in IBD Clinical Trial Design". Gastroenterology 161 2 (2021): 400-404. http://www.scopus.com/inward/record.url?eid=2-s2.0-85111072778&partnerID=MN8TOARS.
    10.1053/j.gastro.2021.03.065
  84. Ferreira-Duarte, Mariana; Tiago Rodrigues-Pinto; Daniela Menezes-Pinto; Marisa Esteves-Monteiro; Salomé Gonçalves-Monteiro; Sara Capas-Peneda; Fernando Magro; et al. "2,4,6-trinitrobenzenesulfonic acid-induced colitis in Rattus norgevicus: a categorization proposal". Experimental Animals (2021): https://www.jstage.jst.go.jp/article/expanim/advpub/0/advpub_20-0113/_article/-char/en.
    Published • https://doi.org/10.1538/expanim.20-0113
  85. Cosme, Dina; Estevinho, Maria Manuela; Rieder, Florian; Magro, Fernando. "Potassium Channels in Intestinal Epithelial Cells and their Pharmacological Modulation: A Systematic Review". American Journal of Physiology-Cell Physiology (2020): http://dx.doi.org/10.1152/ajpcell.00393.2020.
    10.1152/ajpcell.00393.2020
  86. Francisco Jorge Melo; Pedro Pinto-Lopes; Maria Manuela Estevinho; Fernando Magro. "The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review". Inflammatory Bowel Diseases (2020): https://doi.org/10.1093/ibd/izaa324.
    10.1093/ibd/izaa324
  87. Gaspar, Rogério Sá; Silva-Lima, Beatriz; Magro, Fernando; Alcobia, Armando; da Costa, Fernando Leal; Feio, José. "Non-biological Complex Drugs (NBCDs): Complex Pharmaceuticals in Need of Individual Robust Clinical Assessment Before Any Therapeutic Equivalence Decision". Frontiers in Medicine 7 (2020): http://dx.doi.org/10.3389/fmed.2020.590527.
    10.3389/fmed.2020.590527
  88. Maria Manuela Estevinho; Diogo José M. Lopes; Miguel Torre Souto; Fernando Magro. "Inflammatory Bowel Disease in migrant populations – a narrative review". Current Drug Targets (2020): https://doi.org/10.2174/1389450121666201119142045.
    10.2174/1389450121666201119142045
  89. Fernando Magro; Glen Doherty; Laurent Peyrin-Biroulet; Magali Svrcek; Paula Borralho; Alissa Walsh; Fatima Carneiro; et al. "ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology". Journal of Crohn's and Colitis 14 11 (2020): 1503-1511. https://doi.org/10.1093/ecco-jcc/jjaa110.
    10.1093/ecco-jcc/jjaa110
  90. F Magro; J-F Rahier; C Abreu; E MacMahon; A Hart; C J van der Woude; H Gordon; et al. "Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do’s and Don’ts from the ECCO-COVID Taskforce". Journal of Crohn's and Colitis 14 Supplement (2020): S798-S806. https://doi.org/10.1093/ecco-jcc/jjaa160.
    10.1093/ecco-jcc/jjaa160
  91. Ferreira-Duarte, Mariana; Estevinho, Maria Manuela; Duarte-Araújo, Margarida; Magro, Fernando; Morato, Manuela. "Unraveling the Role of ACE2, the Binding Receptor for SARS-CoV-2, in Inflammatory Bowel Disease". Inflammatory Bowel Diseases 26 12 (2020): 1787-1795. http://dx.doi.org/10.1093/ibd/izaa249.
    10.1093/ibd/izaa249
  92. Magro, Fernando; Cordeiro, Gonçalo; Dias, Andreia Martins; Estevinho, Maria Manuela. "Inflammatory Bowel Disease – Non-biological treatment". Pharmacological Research 160 (2020): 105075. http://dx.doi.org/10.1016/j.phrs.2020.105075.
    10.1016/j.phrs.2020.105075
  93. Burisch, Johan; Bergemalm, Daniel; Halfvarson, Jonas; Domislovic, Viktor; Krznaric, Zeljko; Goldis, Adrian; Dahlerup, Jens F; et al. "The use of 5-aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow-up – an Epi-IBD study". United European Gastroenterology Journal 8 8 (2020): 949-960. http://dx.doi.org/10.1177/2050640620945949.
    10.1177/2050640620945949
  94. Fernando Magro; Maria Manuela Estevinho; Cláudia Camila Dias; Luís Correia; Paula Lago; Paula Ministro; Francisco Portela; et al. "Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis". Journal of Crohn's and Colitis (2020): https://doi.org/10.1093/ecco-jcc/jjaa176.
    10.1093/ecco-jcc/jjaa176
  95. Fernando Magro; Maria Manuela Estevinho. "Newborn Congenital Abnormalities and Inflammatory Bowel Disease: Unveiling an Unexplored Relationship". Journal of Crohn's and Colitis 14 8 (2020): 1033-1034. https://doi.org/10.1093/ecco-jcc/jjaa026.
    10.1093/ecco-jcc/jjaa026
  96. Fernando Magro; Catarina Alves; Joanne Lopes; Susana Lopes; Helena Tavares de Sousa; José Cotter; Vitor Macedo da Silva; et al. "Histologic Features of Colon Biopsies (Geboes Score) Associated With Progression of Ulcerative Colitis for the First 36 Months After Biopsy". Clinical Gastroenterology and Hepatology (2020): https://doi.org/10.1016/j.cgh.2020.09.017.
    10.1016/j.cgh.2020.09.017
  97. Santiago, Mafalda; Magro, Fernando; Correia, Luís; Portela, Francisco; Ministro, Paula; Lago, Paula; Trindade, Eunice; Dias, Cláudia Camila. "Inflammatory Bowel Disease Reoperation Rate Has Decreased Over Time If Corrected by Prevalence". Clinical and Translational Gastroenterology 11 9 (2020): e00227. http://dx.doi.org/10.14309/ctg.0000000000000227.
    10.14309/ctg.0000000000000227
  98. Couto, Mafalda R.; Gonçalves, Pedro; Magro, Fernando; Martel, Fátima. "Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease". Pharmacological Research 159 (2020): 104947. http://dx.doi.org/10.1016/j.phrs.2020.104947.
    10.1016/j.phrs.2020.104947
  99. Fernando Magro; Maria Manuela Estevinho. "Is tofacitinib a game-changing drug for ulcerative colitis?". United European Gastroenterology Journal 8 7 (2020): 755-763. https://doi.org/10.1177/2050640620935732.
    10.1177/2050640620935732
  100. Bernstein, Charles N; Ng, Siew C; Banerjee, Rupa; Steinwurz, Flavio; Shen, Bo; Carbonnel, Franck; Hamid, Saeed; et al. "Worldwide Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: An International Survey". Inflammatory Bowel Diseases (2020): http://dx.doi.org/10.1093/ibd/izaa202.
    10.1093/ibd/izaa202
  101. Abreu, Cândida; Palma, Pedro; Prista-Leão, Beatriz; Abreu, Isabel; Costa, Rosário; Sobrinho-Simões, Joana; Cardoso, Maria João; et al. "Prospective study of blood viral load of Epstein-Barr virus, herpes virus type 6 and human parvovirus B19 in Crohn’s disease: Does therapy matter?". Journal of Clinical Virology 129 (2020): 104515. http://dx.doi.org/10.1016/j.jcv.2020.104515.
    10.1016/j.jcv.2020.104515
  102. Paula Sousa; Maria Manuela Estevinho; Cláudia Camila Dias; Paula Ministro; Uri Kopylov; Silvio Danese; Laurent Peyrin-Biroulet; Fernando Magro. "Thiopurines’ Metabolites and Drug Toxicity: A Meta-Analysis". Journal of Clinical Medicine (2020): https://www.mdpi.com/2077-0383/9/7/2216.
    10.3390/jcm9072216
  103. Rubin, David T.; Abreu, Maria T.; Rai, Victoria; Siegel, Corey A.; Ahuja, Vineet; Allez, Matthieu; Ananthakrishnan, Ashwin N.; et al. "Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting". Gastroenterology 159 1 (2020): 6-13.e6. http://dx.doi.org/10.1053/j.gastro.2020.04.002.
    10.1053/j.gastro.2020.04.002
  104. Andreia M. Dias; Gonçalo Cordeiro; Maria M. Estevinho; Rui Veiga; Luis Figueira; Marta Reina-Couto; Fernando Magro. "Gut bacterial microbiome composition and statin intake—A systematic review". Pharmacology Research & Perspectives 8 3 (2020): https://doi.org/10.1002/prp2.601.
    10.1002/prp2.601
  105. Fernando Magro; Claudia Camila Dias; Manuela Morato. "Aminosalicylates and COVID-19: Facts or Coincidences?". Gastroenterology (2020): https://doi.org/10.1053/j.gastro.2020.05.092.
    10.1053/j.gastro.2020.05.092
  106. Magro, Fernando; Drenth, Joost PH. "Gastroenterological features of COVID-19 and the role of the United European Gastroenterology Journal". United European Gastroenterology Journal 8 5 (2020): 505-506. http://dx.doi.org/10.1177/2050640620926832.
    10.1177/2050640620926832
  107. Magro, Fernando; Abreu, Candida; Rahier, Jean-François. "The daily impact of COVID-19 in gastroenterology". United European Gastroenterology Journal 8 5 (2020): 520-527. http://dx.doi.org/10.1177/2050640620920157.
    10.1177/2050640620920157
  108. Rosa, Isadora; Silva, Patrícia; da Mata, Sara; Magro, Fernando; Carneiro, Fátima; Peixoto, Armando; Silva, Marco; et al. "Methylation patterns in dysplasia in inflammatory bowel disease patients". Scandinavian Journal of Gastroenterology 55 6 (2020): 646-655. http://dx.doi.org/10.1080/00365521.2020.1766552.
    10.1080/00365521.2020.1766552
  109. Estevinho, Maria Manuela; Rocha, Cátia; Correia, Luís; Lago, Paula; Ministro, Paula; Portela, Francisco; Trindade, Eunice; et al. "Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic Review". Clinical Gastroenterology and Hepatology 18 5 (2020): 1054-1069. http://dx.doi.org/10.1016/j.cgh.2019.08.063.
    10.1016/j.cgh.2019.08.063
  110. Pereira, Márcia S.; Durães, Cecília; Catarino, Telmo A.; Costa, José L.; Cleynen, Isabelle; Novokmet, Mislav; Krištic, Jasminka; et al. "Genetic Variants of the MGAT5 Gene Are Functionally Implicated in the Modulation of T Cells Glycosylation and Plasma IgG Glycome Composition in Ulcerative Colitis". Clinical and Translational Gastroenterology 11 4 (2020): e00166. http://dx.doi.org/10.14309/ctg.0000000000000166.
    10.14309/ctg.0000000000000166
  111. Séverine Vermeire; Milan Lukáš; Fernando Magro; Shashi Adsul; Dirk Lindner; Maria Rosario; Jeannine Roth; Silvio Danese. "Vedolizumab Efficacy, Safety, and Pharmacokinetics with Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients with Crohn’s Disease or Ulcerative Colitis". Journal of Crohn's and Colitis (2020): https://doi.org/10.1093/ecco-jcc/jjaa027.
    10.1093/ecco-jcc/jjaa027
  112. Fernando Magro; Maria Manuela Estevinho. "Is Faecal Calprotectin Important in Detecting Silent Gut Inflammation in Seronegative Arthropathies?". Journal of Crohn's and Colitis (2020): https://doi.org/10.1093/ecco-jcc/jjaa011.
    10.1093/ecco-jcc/jjaa011
  113. D’Amico, Ferdinando; Pouillon, Lieven; Argollo, Marjorie; Hart, Ailsa; Fiorino, Gionata; Vegni, Elena; Radice, Simona; et al. "Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group". Digestive and Liver Disease 52 2 (2020): 138-142. http://dx.doi.org/10.1016/j.dld.2019.11.004.
    10.1016/j.dld.2019.11.004
  114. Helena Tavares De Sousa; Maria Manuela Estevinho; Laurent Peyrin-Biroulet; Silvio Danese; Cláudia Camila Dias; Fátima Carneiro; Fernando Magro. "Transmural Histological Scoring Systems in Crohn’s Disease: A Systematic Review With Assessment of Methodological Quality and Operating Properties". Journal of Crohn's and Colitis (2020): https://doi.org/10.1093/ecco-jcc/jjz178.
    10.1093/ecco-jcc/jjz178
  115. Fernando Magro; Joanne Lopes; Paula Borralho; Cláudia Camila Dias; Joana Afonso; Paula Ministro; Mafalda Santiago; et al. "Comparison of the Nancy Index With Continuous Geboes Score: Histological Remission and Response in Ulcerative Colitis". Journal of Crohn's and Colitis (2020): https://doi.org/10.1093/ecco-jcc/jjaa010.
    10.1093/ecco-jcc/jjaa010
  116. Pedro Pinto-Lopes; Joana Afonso; Rui Pinto-Lopes; Cátia Rocha; Paula Lago; Raquel Gonc¸alves; Helena Tavares De Sousa; et al. "Serum Dipeptidyl Peptidase 4: A Predictor of Disease Activity and Prognosis in Inflammatory Bowel Disease". Inflammatory Bowel Diseases (2020): https://doi.org/10.1093/ibd/izz319.
    10.1093/ibd/izz319
  117. Fernando Magro; Maria Manuela Estevinho. "Do Neutrophils Contribute to Development of Crohn’s Disease and Ulcerative Colitis?"". Clinical Gastroenterology and Hepatology (2020): https://doi.org/10.1016/j.cgh.2020.01.032.
    10.1016/j.cgh.2020.01.032
  118. Mafalda Santiago; Fernando Magro; Luís Correia; Francisco Portela; Paula Ministro; Paula Lago; Eunice Trindade; Cláudia Camila Dias. "Rehospitalization rates, costs, and risk factors for inflammatory bowel disease: a 16-year nationwide study". Therapeutic Advances in Gastroenterology (2020): https://doi.org/10.1177/1756284820923836.
    10.1177/1756284820923836
  119. Rocha, Cátia; Lago, Paula; Fernandes, Samuel; Correia, Luís; Portela, Francisco; Vieira, Ana Isabel; Patita, Marta; et al. "Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassays". Therapeutic Advances in Gastroenterology 13 (2020): 175628482096579. http://dx.doi.org/10.1177/1756284820965790.
    10.1177/1756284820965790
  120. Estevinho, Maria Manuela; Magro, Fernando. "The Impact of SARS-CoV-2 on Inflammatory Bowel Disease". GE - Portuguese Journal of Gastroenterology 27 4 (2020): 227-229. http://dx.doi.org/10.1159/000508114.
    10.1159/000508114
  121. D'Amico, F.; Danese, S.; Peyrin-Biroulet, L.; Ailsa, H.; Kucharzik, T.; Magro, F.; Rahier, J.-F.; et al. "Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn's and Colitis Organization". Gastroenterology 159 1 (2020): 14-19.e3. http://www.scopus.com/inward/record.url?eid=2-s2.0-85088240916&partnerID=MN8TOARS.
    10.1053/j.gastro.2020.04.059
  122. Burisch, J.; Vardi, H.; Schwartz, D.; Friger, M.; Kiudelis, G.; Kupcinskas, J.; Fumery, M.; et al. "Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study". The Lancet Gastroenterology and Hepatology 5 5 (2020): 454-464. http://www.scopus.com/inward/record.url?eid=2-s2.0-85082745423&partnerID=MN8TOARS.
    10.1016/S2468-1253(20)30012-1
  123. Ferreira-Duarte, Mariana; Maria Manuela Estevinho; Margarida Duarte-Araujo; Fernando Magro; Manuela Morato. "Unravelling the role of ACE2, the binding receptor for SARS-CoV-2, in Inflammatory Bowel Disease". Inflammatory Bowel Diseases 16 12 (2020): 1787-1795.
    Published • 10.1093/ibd/izaa249
  124. Chateau, Thomas; Feakins, Roger; Marchal-Bressenot, Aude; Magro, Fernando; Danese, Silvio; Peyrin-Biroulet, Laurent. "Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure". American Journal of Gastroenterology 115 2 (2019): 179-189. http://dx.doi.org/10.14309/ajg.0000000000000437.
    10.14309/ajg.0000000000000437
  125. Adamina, Michel; Bonovas, Stefanos; Raine, Tim; Spinelli, Antonino; Warusavitarne, Janindra; Armuzzi, Alessandro; Bachmann, Oliver; et al. "ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment". Journal of Crohn's and Colitis 14 2 (2019): 155-168. http://dx.doi.org/10.1093/ecco-jcc/jjz187.
    10.1093/ecco-jcc/jjz187
  126. Torres, Joana; Bonovas, Stefanos; Doherty, Glen; Kucharzik, Torsten; Gisbert, Javier P; Raine, Tim; Adamina, Michel; et al. "ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment". Journal of Crohn's and Colitis 14 1 (2019): 4-22. http://dx.doi.org/10.1093/ecco-jcc/jjz180.
    10.1093/ecco-jcc/jjz180
  127. Magro, Fernando; Estevinho, Maria Manuela. "Moving from efficacy to effectiveness: budesonide multimatrix in ulcerative colitis". United European Gastroenterology Journal 7 9 (2019): 1153-1155. http://dx.doi.org/10.1177/2050640619878588.
    10.1177/2050640619878588
  128. Portela, Francisco; Ministro, Paula; de Deus, João; Cravo, Marilia; Cotter, José; Duque, Gabriela; Ferreira, Frederico; et al. "Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Surgical Intervention versus Immunomodulatory Therapy". Digestion 101 5 (2019): 631-637. http://dx.doi.org/10.1159/000501823.
    10.1159/000501823
  129. Magro, Fernando; Lopes, Joanne; Borralho, Paula; Lopes, Susana; Coelho, Rosa; Cotter, José; Dias de Castro, Francisca; et al. "Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels". Journal of Crohn's and Colitis 14 2 (2019): 169-175. http://dx.doi.org/10.1093/ecco-jcc/jjz123.
    10.1093/ecco-jcc/jjz123
  130. Roseira, Joana; Magro, Fernando; Fernandes, Samuel; Simões, Carolina; Portela, Francisco; Vieira, Ana Isabel; Patita, Marta; et al. "Sexual Quality of Life in Inflammatory Bowel Disease: A Multicenter, National-Level Study". Inflammatory Bowel Diseases 26 5 (2019): 746-755. http://dx.doi.org/10.1093/ibd/izz185.
    10.1093/ibd/izz185
  131. Cláudia Camila Dias; Mafalda Santiago; Luís Correia; Francisco Portela; Paula Ministro; Paula Lago; Eunice Trindade; Alberto Freitas; Fernando Magro. "Hospitalization trends of the Inflammatory Bowel Disease landscape: A nationwide overview of 16 years". Digestive and Liver Disease 51 7 (2019): 952-960. https://doi.org/10.1016/j.dld.2019.01.016.
    10.1016/j.dld.2019.01.016
  132. Magro, F; Lopes, S; Silva, M; Coelho, R; Portela, F; Branquinho, D; Correia, L; et al. "Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study". Journal of Crohn's and Colitis 13 11 (2019): 1387-1393. http://dx.doi.org/10.1093/ecco-jcc/jjz071.
    10.1093/ecco-jcc/jjz071
  133. Pouillon, Lieven; Danese, Silvio; Hart, Ailsa; Fiorino, Gionata; Argollo, Marjorie; Selmi, Carlo; Carlo-Stella, Carmelo; et al. "Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients". Alimentary Pharmacology & Therapeutics 49 9 (2019): 1181-1187. http://dx.doi.org/10.1111/apt.15223.
    10.1111/apt.15223
  134. Magro, Fernando; Coelho, Rosa; Peixoto, Armando. "Can We Extrapolate Data from One Immune-Mediated Inflammatory Disease to Another One?". Current Medicinal Chemistry 26 2 (2019): 248-258. http://dx.doi.org/10.2174/0929867325666181101114937.
    10.2174/0929867325666181101114937
  135. Burisch, Johan; Zammit, Stefania Chetcuti; Ellul, Pierre; Turcan, Svetlana; Duricova, Dana; Bortlik, Martin; Andersen, Karina Winther; et al. "Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study". Journal of Gastroenterology and Hepatology 34 6 (2019): 996-1003. http://dx.doi.org/10.1111/jgh.14563.
    10.1111/jgh.14563
  136. Fernando Magro; Susana Lopes; Marco Silva; Rosa Coelho; Francisco Portela; Diogo Branquinho; Luís Correia; et al. "Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab". Therapeutic Advances in Gastroenterology 12 (2019): 175628481986914-175628481986914. https://doi.org/10.1177/1756284819869141.
    10.1177/1756284819869141
  137. Mafalda Santiago; Fernando Magro; Luís Correia; Francisco Portela; Paula Ministro; Paula Lago; Cláudia Camila Dias. "What forecasting the prevalence of inflammatory bowel disease may tell us about its evolution on a national scale". Therapeutic Advances in Gastroenterology 12 (2019): 175628481986004-175628481986004. https://doi.org/10.1177/1756284819860044.
    10.1177/1756284819860044
  138. Rocha, Cátia; Afonso, Joana; Lago, Paula; Arroja, Bruno; Vieira, Ana I.; Dias, Cláudia C.; Magro, Fernando. "Accuracy of the new rapid test for monitoring adalimumab levels". (2019): http://hdl.handle.net/10451/39728.
    10.1177/1756284819828238
  139. Magro, Fernando; Lopes, Joanne; Borralho, Paula; Lopes, Susana; Coelho, Rosa; Cotter, Jose; de Castro, Francisca Dias; et al. "Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels". (2019): http://hdl.handle.net/10400.1/14370.
    10.1136/gutjnl-2017-315545
  140. Danese, Silvio; Allez, Matthieu; van Bodegraven, Ad A.; Dotan, Iris; Gisbert, Javier P.; Hart, Ailsa; Lakatos, Peter L.; et al. "Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus". Digestive Diseases 37 4 (2019): 266-283. http://dx.doi.org/10.1159/000496739.
    10.1159/000496739
  141. Lopes, S.; Costa-Silva, M.; Magina, S.; Silva, M.; Magro, F.; Azevedo, F.; Lisboa, C.. "Concurrent Lip Chancre and Maculopapular Syphilides in a Patient under Anti-TNFa Therapy". Skinmed 17 5 (2019): 343-345. http://www.scopus.com/inward/record.url?eid=2-s2.0-85075783939&partnerID=MN8TOARS.
  142. Domènech, E.; Panés, J.; Hinojosa, J.; Annese, V.; Magro, F.; Sturniolo, G.C.; Bossa, F.; et al. "Corrigendum: Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial (Journal of Crohn's and Colitis DOI: 10.1093/ecco-jcc/jjy023)". Journal of Crohn's and Colitis 13 6 (2019): 814-814. http://www.scopus.com/inward/record.url?eid=2-s2.0-85066920376&partnerID=MN8TOARS.
    10.1093/ecco-jcc/jjy211
  143. Magro, F.; Magro, Fernando. "Anti-TNF treatment failure: drug levels, immunogenicity, or both?". The Lancet Gastroenterology and Hepatology 4 5 (2019): 326-327. http://www.scopus.com/inward/record.url?eid=2-s2.0-85063680533&partnerID=MN8TOARS.
    10.1016/S2468-1253(19)30044-5
  144. Magro, F.; Dias, C.C.; Portela, F.; Miranda, M.; Fernandes, S.; Bernardo, S.; Ministro, P.; et al. "Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network Analysis". Journal of Crohn's and Colitis 13 4 (2019): 401-409. http://www.scopus.com/inward/record.url?eid=2-s2.0-85063963088&partnerID=MN8TOARS.
    10.1093/ecco-jcc/jjy168
  145. Chetcuti Zammit, Stefania; Ellul, Pierre; Girardin, Giulia; Valpiani, Daniela; Nielsen, Kári R.; Olsen, Jóngerð; Goldis, Adrian; et al. "Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study". European Journal of Gastroenterology & Hepatology 30 11 (2018): 1297-1303. http://dx.doi.org/10.1097/meg.0000000000001238.
    10.1097/meg.0000000000001238
  146. Burisch, Johan; Katsanos, Konstantinos H; Christodoulou, Dimitrios K; Barros, Luisa; Magro, Fernando; Pedersen, Natalia; Kjeldsen, Jens; et al. "Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD Study". Journal of Crohn's and Colitis 13 2 (2018): 198-208. http://dx.doi.org/10.1093/ecco-jcc/jjy154.
    10.1093/ecco-jcc/jjy154
  147. J. Goncalves; F. Magro; S. Danese; P. L. Lakatos; S. Ben-Horin. "Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors’ reply". Alimentary Pharmacology & Therapeutics 48 5 (2018): 575-576. https://doi.org/10.1111/apt.14860.
    10.1111/apt.14860
  148. Estevinho, Maria Manuela; Afonso, Joana; Rosa, Isadora; Lago, Paula; Trindade, Eunice; Correia, Luís; Dias, Cláudia Camila; Magro, Fernando. "Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis". Journal of Crohn's and Colitis 12 10 (2018): 1232-1244. http://dx.doi.org/10.1093/ecco-jcc/jjy100.
    10.1093/ecco-jcc/jjy100
  149. Sousa, Helena Tavares de; Brito, Jorge; Magro, Fernando. "New cross-sectional imaging in IBD". Current Opinion in Gastroenterology 34 4 (2018): 194-207. http://dx.doi.org/10.1097/mog.0000000000000440.
    10.1097/mog.0000000000000440
  150. Ferreiro-Iglesias, Rocío; Magro, Fernando. "Young GI angle: Tips and tricks for an academic career". United European Gastroenterology Journal 6 6 (2018): 952-954. http://dx.doi.org/10.1177/2050640618783674.
    10.1177/2050640618783674
  151. Goncalves, J.; Santos, M.; Acurcio, R.; Iria, I.; Gouveia, L.; Matos Brito, P.; Catarina Cunha-Santos, A.; et al. "Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition". Alimentary Pharmacology & Therapeutics 48 5 (2018): 507-522. http://dx.doi.org/10.1111/apt.14808.
    10.1111/apt.14808
  152. Charbit-Henrion, Fabienne; Parlato, Marianna; Hanein, Sylvain; Duclaux-Loras, Rémi; Nowak, Jan; Begue, Bernadette; Rakotobe, Sabine; et al. "Diagnostic Yield of Next-generation Sequencing in Very Early-onset Inflammatory Bowel Diseases: A Multicentre Study". Journal of Crohn's and Colitis 12 9 (2018): 1104-1112. http://dx.doi.org/10.1093/ecco-jcc/jjy068.
    10.1093/ecco-jcc/jjy068
  153. Miehlke, Stephan; Acosta, Manuel Barreiro-de; Bouma, Gerd; Carpio, Daniel; Magro, Fernando; Moreels, Tom; Probert, Chris. "Oral budesonide in gastrointestinal and liver disease: A practical guide for the clinician". Journal of Gastroenterology and Hepatology 33 9 (2018): 1574-1581. http://dx.doi.org/10.1111/jgh.14151.
    10.1111/jgh.14151
  154. Cláudia Camila Dias; Francisco Portela; Samuel Fernandes; Paula Ministro; Paula Lago; Isadora Rosa; Luis Correia; Fernando Magro. "The timing of early therapeutic strategies has a significant impact on Crohn’s disease prognosis". Digestive and Liver Disease 50 5 (2018): 462-468. https://doi.org/10.1016/j.dld.2018.01.135.
    10.1016/j.dld.2018.01.135
  155. F. Magro; H. T. Sousa. "Editorial: ulcerative colitis submucosal fibrosis and inflammation: more than just strictures". Alimentary Pharmacology & Therapeutics 47 7 (2018): 1033-1034. https://doi.org/10.1111/apt.14575.
    10.1111/apt.14575
  156. Chaparro, M; Verreth, A; Lobaton, T; Gravito-Soares, E; Julsgaard, M; Savarino, E; Magro, F; et al. "Long-Term Safety of In Utero Exposure to Anti-TNFa Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study". American Journal of Gastroenterology 113 3 (2018): 396-403. http://dx.doi.org/10.1038/ajg.2017.501.
    10.1038/ajg.2017.501
  157. Domènech, Eugeni; Panés, Julián; Hinojosa, Joaquín; Annese, Vito; Magro, Fernando; Sturniolo, Giacomo Carlo; Bossa, Fabrizio; et al. "Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial". Journal of Crohn's and Colitis 12 6 (2018): 687-694. http://dx.doi.org/10.1093/ecco-jcc/jjy023.
    10.1093/ecco-jcc/jjy023
  158. Burisch, Johan; Kiudelis, Gediminas; Kupcinskas, Limas; Kievit, Hendrika Adriana Linda; Andersen, Karina Winther; Andersen, Vibeke; Salupere, Riina; et al. "Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study". Gut 68 3 (2018): 423-433. http://dx.doi.org/10.1136/gutjnl-2017-315568.
    10.1136/gutjnl-2017-315568
  159. Lopes, Susana; Andrade, Patrícia; Afonso, Joana; Cunha, Rui; Rodrigues-Pinto, Eduardo; Ramos, Isabel; Macedo, Guilherme; Magro, Fernando. "Monitoring Crohn’s disease activity: endoscopy, fecal markers and computed tomography enterography". Therapeutic Advances in Gastroenterology 11 (2018): 175628481876907. http://dx.doi.org/10.1177/1756284818769075.
    10.1177/1756284818769075
  160. Inês Pita; Fernando Magro. "Advanced imaging techniques for small bowel Crohn’s disease: what does the future hold?". Therapeutic Advances in Gastroenterology 11 (2018): 1756283X1875718-1756283X1875718. https://doi.org/10.1177/1756283X18757185.
    10.1177/1756283X18757185
  161. Magro, F.; Rocha, C.; Vieira, A. I.; Sousa, H. T.; Rosa, I.; Lopes, S.; Carvalho, J.; Dias, C. C.; Afonso, J.. "The performance of Remicade®-optimized quantification assays in the assessment of Flixabi® levels". Therapeutic Advances in Gastroenterology 11 (2018): 175628481879695. http://dx.doi.org/10.1177/1756284818796956.
    10.1177/1756284818796956
  162. Lopes, Susana; Andrade, Patricia; Cunha, Rui; Magro, Fernando. "Transmural healing in Crohn’s disease: Beyond mural findings". Digestive and Liver Disease 50 1 (2018): 103-104. http://dx.doi.org/10.1016/j.dld.2017.09.134.
    10.1016/j.dld.2017.09.134
  163. Peyrin-Biroulet, Laurent; Baumgart, Daniel C.; Armuzzi, Alessandro; Gionchetti, Paolo; Sebastian, Shaji; Danese, Silvio; Magro, Fernando; et al. "Quality of Care in Ulcerative Colitis: A Modified Delphi Panel Approach". Digestive Diseases 36 5 (2018): 346-353. http://dx.doi.org/10.1159/000489845.
    10.1159/000489845
  164. Vide, J.; Osório, F.; Costa-Silva, M.; Lopes, S.; Azevedo, F.; Dias, C.C.; Magina, S.; et al. "Cutaneous morbidity among inflammatory bowel disease patients: A cohort study". Journal of Crohn's and Colitis 12 4 (2018): 442-451. http://www.scopus.com/inward/record.url?eid=2-s2.0-85052539911&partnerID=MN8TOARS.
    10.1093/ECCO-JCC/JJX178
  165. Cândida Abreu; António Sarmento; Fernando Magro. "Screening, prophylaxis and counselling before the start of biological therapies: A practical approach focused on IBD patients". Digestive and Liver Disease 49 12 (2017): 1289-1297. https://doi.org/10.1016/j.dld.2017.09.002.
    10.1016/j.dld.2017.09.002
  166. Lopes, Susana; Rodrigues-Pinto, Eduardo; Andrade, Patrícia; Afonso, Joana; Baron, Todd H; Magro, Fernando; Macedo, Guilherme. "Endoscopic balloon dilation of Crohn’s disease strictures-safety, efficacy and clinical impact". World Journal of Gastroenterology 23 41 (2017): 7397-7406. http://dx.doi.org/10.3748/wjg.v23.i41.7397.
    10.3748/wjg.v23.i41.7397
  167. Magalhães, Diogo; Soares-da-Silva, Patrício; Magro, Fernando. "The effect of PRR ligands on the membrane potential of intestinal epithelial cells". Pharmacological Reports 69 5 (2017): 978-984. http://dx.doi.org/10.1016/j.pharep.2017.04.010.
    10.1016/j.pharep.2017.04.010
  168. Lopes, Susana; Andrade, Patrícia; Rodrigues-Pinto, Eduardo; Afonso, Joana; Macedo, Guilherme; Magro, Fernando. "Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn’s disease patients with anastomotic strictures". World Journal of Gastroenterology 23 35 (2017): 6482-6490. http://dx.doi.org/10.3748/wjg.v23.i35.6482.
    10.3748/wjg.v23.i35.6482
  169. Estevinho, M. M.; Afonso, J.; Rosa, I.; Lago, P.; Trindade, E.; Correia, L.; Dias, C. C.; Magro, F.. "Levels of 6-thioguanine nucleotides and clinical remission in inflammatory bowel disease – A systematic review and meta-analysis". Porto Biomedical Journal 2 5 (2017): 198-199. http://dx.doi.org/10.1016/j.pbj.2017.07.055.
    10.1016/j.pbj.2017.07.055
  170. Lopes, Susana; Andrade, Patricia; Conde, Silvia; Liberal, Rodrigo; Dias, Cláudia C.; Fernandes, Salomão; Pinheiro, Jorge; et al. "Looking into Enteric Virome in Patients with IBD". Inflammatory Bowel Diseases 23 8 (2017): 1278-1284. http://dx.doi.org/10.1097/mib.0000000000001167.
    10.1097/mib.0000000000001167
  171. Lemos, Vera; de Oliveira, Rita M; Naia, Luana; Szegö, Éva; Ramos, Elisabete; Pinho, Sónia; Magro, Fernando; et al. "The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes". Human Molecular Genetics 26 21 (2017): 4105-4117. http://dx.doi.org/10.1093/hmg/ddx298.
    10.1093/hmg/ddx298
  172. Fernando Magro; Joana Afonso; Susana Lopes; Rosa Coelho; Raquel Gonçalves; Paulo Caldeira; Paula Lago; et al. "Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation". EBioMedicine 21 (2017): 123-130. https://doi.org/10.1016/j.ebiom.2017.06.004.
    10.1016/j.ebiom.2017.06.004
  173. Estevinho, Maria Manuela; Afonso, Joana; Rosa, Isadora; Lago, Paula; Trindade, Eunice; Correia, Luís; Dias, Cláudia Camila; Magro, Fernando. "A Systematic Review and Meta-Analysis of 6-Thioguanine Nucleotide Levels and Clinical Remission in Inflammatory Bowel Disease". Journal of Crohn's and Colitis 11 11 (2017): 1381-1392. http://dx.doi.org/10.1093/ecco-jcc/jjx089.
    10.1093/ecco-jcc/jjx089
  174. Abreu, Cândida; Afonso, Joana; Camila Dias, Cláudia; Ruas, Rogério; Sarmento, António; Magro, Fernando. "Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFa Therapy". Journal of Crohn's and Colitis 11 10 (2017): 1223-1229. http://dx.doi.org/10.1093/ecco-jcc/jjx080.
    10.1093/ecco-jcc/jjx080
  175. Burisch, Johan; Vegh, Zsuzsanna; Katsanos, Konstantinnos H; Christodoulou, Dimitrios K; Lazar, Daniela; Goldis, Adrian; O’Morain, Colm; et al. "Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort—An ECCO-EpiCom Study". Journal of Crohn's and Colitis 11 10 (2017): 1213-1222. http://dx.doi.org/10.1093/ecco-jcc/jjx077.
    10.1093/ecco-jcc/jjx077
  176. Dias, Cláudia Camila; Pereira Rodrigues, Pedro; Fernandes, Samuel; Portela, Francisco; Ministro, Paula; Martins, Diana; Sousa, Paula; et al. "The risk of disabling, surgery and reoperation in Crohn’s disease – A decision tree-based approach to prognosis". PLOS ONE 12 2 (2017): e0172165. http://dx.doi.org/10.1371/journal.pone.0172165.
    10.1371/journal.pone.0172165
  177. Magro, Fernando; Gionchetti, Paolo; Eliakim, Rami; Ardizzone, Sandro; Armuzzi, Alessandro; Barreiro-de Acosta, Manuel; Burisch, Johan; et al. "Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders". Journal of Crohn's and Colitis 11 6 (2017): 649-670. http://dx.doi.org/10.1093/ecco-jcc/jjx008.
    10.1093/ecco-jcc/jjx008
  178. Portela, Francisco; Dias, Camila C.; Caldeira, Paulo; Cravo, Marilia; Deus, João; Gonçalves, Raquel; Lago, Paula; et al. "The who-when-why triangle of complementary and alternative medicine use among Portuguese IBD patients". (2017): http://hdl.handle.net/10400.1/13167.
    10.1016/j.dld.2016.12.031
  179. Dias, Cláudia Camila; Rodrigues, Pedro Pereira; Coelho, Rosa; Santos, Paula Moura; Fernandes, Samuel; Lago, Paula; Caetano, Cidalina; et al. "Development and validation of risk matrices for Crohn's Disease outcomes in patients who underwent early therapeutic interventions". (2017): http://hdl.handle.net/10400.1/13174.
    10.1093/ecco-jcc/jjw171
  180. Afonso, Joana; de Sousa, Helena Tavares; Rosa, Isadora; Carvalho, João; Dias, Claudia Camila; Magro, Fernando. "Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays". (2017): http://hdl.handle.net/10400.1/11906.
    10.1177/1756283X17722915
  181. Magro, Fernando; Afonso, Joana; Lopes, Susana; Coelho, Rosa; Gonçalves, Raquel; Caldeira, Paulo; Lago, Paula; et al. "Clinical performance of an infliximab rapid quantification assay". (2017): http://hdl.handle.net/10400.1/11905.
    10.1177/1756283X17722916
  182. Magro, Fernando; Lopes, Susana; Coelho, Rosa; Cotter, Jose; Castro, Francisca Dias de; Sousa, Helena Tavares; Salgado, Marta; et al. "Accuracy of faecal calprotectin and neutrophil Gelatinase B-associated Lipocalin in evaluating subclinical inflammation in UlceRaTIVE colitis-the ACERTIVE study". (2017): http://hdl.handle.net/10400.1/11084.
    10.1093/ecco-jcc/jjw170
  183. Magro, Fernando; Dias, Cláudia C.; Coelho, Rosa; Santos, Paula M.; Fernandes, Samuel; Caetano, Cidalina; Rodrigues, Angela; et al. "Impact of early surgery and immunosuppression on Crohn's disease disabling outcomes". (2017): http://hdl.handle.net/10400.1/13244.
    10.1097/MIB.0000000000001007
  184. Costa Pereira, Cristiana; Durães, Cecília; Coelho, Rosa; Grácio, Daniela; Silva, Marco; Peixoto, Armando; Lago, Paula; et al. "Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease". (2017): http://hdl.handle.net/10400.18/5429.
    10.1371/journal.pone.0169102
  185. Peixoto, Armando; Coelho, Rosa; Maia, Tiago; Sarmento, António; Magro, Fernando; Macedo, Guilherme. "Chronic Granulomatous Disease Mimicking Colonic Crohn's Disease Successfully Treated with Infliximab". ACG Case Reports Journal 4 1 (2017): e46. http://dx.doi.org/10.14309/crj.2017.46.
    10.14309/crj.2017.46
  186. Dias, C.C.; Rodrigues, P.P.; Coelho, R.; Santos, P.M.; Fernandes, S.; Lago, P.; Caetano, C.; et al. "Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions [J Crohns Colitis. 11, 4, (2017) 445-453] doi:10.1093/ecco-jcc/jjw171". Journal of Crohn's and Colitis 11 4 (2017): 515-515. http://www.scopus.com/inward/record.url?eid=2-s2.0-85029063843&partnerID=MN8TOARS.
    10.1093/ecco-jcc/jjw207
  187. Kopylov, U.; Papamichael, K.; Katsanos, K.; Waterman, M.; Bar-Gil Shitrit, A.; Boysen, T.; Portela, F.; et al. "Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus - A Multicenter Retrospective Study". Inflammatory Bowel Diseases 23 9 (2017): 1605-1613. http://www.scopus.com/inward/record.url?eid=2-s2.0-85028333906&partnerID=MN8TOARS.
    10.1097/MIB.0000000000001160
  188. Abreu, Cândida; Almeida, Francisco; Ferraz, Rita; Dias, Claúdia Camila; Sarmento, António; Magro, Fernando. "The tuberculin skin test still matters for the screening of latent Tuberculosis infections among Inflammatory Bowel Disease patients". Digestive and Liver Disease 48 12 (2016): 1438-1443. http://dx.doi.org/10.1016/j.dld.2016.08.107.
    10.1016/j.dld.2016.08.107
  189. Fiorino, Gionata; Cortes, Pablo Navarro; Ellul, Pierre; Felice, Carla; Karatzas, Pantelis; Silva, Marco; Lakatos, Peter L.; et al. "Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study". Clinical Gastroenterology and Hepatology 14 10 (2016): 1426-1432.e1. http://dx.doi.org/10.1016/j.cgh.2016.05.044.
    10.1016/j.cgh.2016.05.044
  190. Silva-Ferreira, Filipa; Afonso, Joana; Pinto-Lopes, Pedro; Magro, Fernando; Silva-Ferreira, F.; Afonso, J.; Pinto-Lopes, P.; Magro, F.. "A Systematic Review on Infliximab and Adalimumab Drug Monitoring". Inflammatory Bowel Diseases 22 9 (2016): 2289-2301. http://dx.doi.org/10.1097/mib.0000000000000855.
    10.1097/mib.0000000000000855
  191. Afonso, J.; Lopes, S.; Gonçalves, R.; Caldeira, P.; Lago, P.; Tavares de Sousa, H.; Ramos, J.; et al. "Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays". Alimentary Pharmacology & Therapeutics 44 7 (2016): 684-692. http://dx.doi.org/10.1111/apt.13757.
    10.1111/apt.13757
  192. Magro, Fernando; Lopes, Susana Isabel; Lopes, Joanne; Portela, Francisco; Cotter, José; Lopes, Sandra; Moreira, Maria João; et al. "Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab". Journal of Crohn's and Colitis 10 12 (2016): 1407-1416. http://dx.doi.org/10.1093/ecco-jcc/jjw112.
    10.1093/ecco-jcc/jjw112
  193. Magalhães, Diogo; Cabral, José Miguel; Soares-da-Silva, Patrício; Magro, Fernando. "Role of epithelial ion transports in inflammatory bowel disease". American Journal of Physiology-Gastrointestinal and Liver Physiology 310 7 (2016): G460-G476. http://dx.doi.org/10.1152/ajpgi.00369.2015.
    10.1152/ajpgi.00369.2015
  194. Magro, F.; Coelho, R.; Guimarães, L.S.; Silva, M.; Peixoto, A.; Lopes, S.; Macedo, G.. "Anti-TNF therapy and radiation exposure in Crohn's disease: chicken or egg?". Scandinavian journal of gastroenterology 51 4 (2016): 511-512. http://www.scopus.com/inward/record.url?eid=2-s2.0-84973409831&partnerID=MN8TOARS.
    10.3109/00365521.2015.1105287
  195. Magro, F.; Ramos, J.; Correia, L.; Lago, P.; Peixe, P.; Gonçalves, A.R.; Rodrigues, Â.; et al. "Portuguese consensus on the diagnosis, prevention and treatment of anaemia in inflammatory bowel disease | Consenso português sobre o diagnóstico, prevenção e tratamento da anemia na doença inflamatória intestinal". Acta Medica Portuguesa 29 2 (2016): 144-156. http://www.scopus.com/inward/record.url?eid=2-s2.0-84959329314&partnerID=MN8TOARS.
    10.20344/amp.6058
  196. Coelho, R.; Silva, M.; Gaspar, R.; Silva, R.; Paiva, D.; Lopes, J.; Lopes, S.; et al. "“A book should not be judged by its cover”: two cases of intestinal adenocarcinoma as the first manifestation of Crohn’s disease". International Journal of Colorectal Disease 31 5 (2016): 1061-1062. http://www.scopus.com/inward/record.url?eid=2-s2.0-84944586927&partnerID=MN8TOARS.
    10.1007/s00384-015-2389-1
  197. Abreu, C.; Sarmento, A.; Magro, F.. "Reintroduction of anti-TNFa therapy after (or even during) anti-TNFa-associated tuberculosis in immune-mediated diseases". Journal of Crohn's and Colitis 10 1 (2016): 120-121. http://www.scopus.com/inward/record.url?eid=2-s2.0-84963724929&partnerID=MN8TOARS.
    10.1093/ecco-jcc/jjv172
  198. Coelho, R.; Peixoto, A.; Amil-Dias, J.; Trindade, E.; Campos, M.; Magina, S.; Charbit-Henrion, F.; et al. "Refractory monogenic Crohn’s disease due to X-linked inhibitor of apoptosis deficiency". International Journal of Colorectal Disease 31 6 (2016): 1235-1236. http://www.scopus.com/inward/record.url?eid=2-s2.0-84947552540&partnerID=MN8TOARS.
    10.1007/s00384-015-2442-0
  199. Coelho, R.; Magro, F.; Silva, M.; Macedo, G.. "Early surgery in Crohn's disease patients with entero-urinary fistulas: Does it change the prognosis?". Scandinavian Journal of Gastroenterology 51 6 (2016): 679-683. http://www.scopus.com/inward/record.url?eid=2-s2.0-84957972419&partnerID=MN8TOARS.
    10.3109/00365521.2015.1124916
  200. Portela, F.; Lago, P.; Cotter, J.; Gonçalves, R.; Vasconcelos, H.; Ministro, P.; Lopes, S.; et al. "Anaemia in patients with inflammatory bowel disease - A nationwide cross-sectional study". Digestion 93 3 (2016): 214-220. http://www.scopus.com/inward/record.url?eid=2-s2.0-84962022340&partnerID=MN8TOARS.
    10.1159/000443927
  201. Cabral, J.M.; Grácio, D.; Soares-Da-Silva, P.; Magro, F.. "Short- and long-term regulation of intestinal Na+/H+ exchange by toll-like receptors TLR4 and TLR5". American Journal of Physiology - Gastrointestinal and Liver Physiology 309 8 (2016): G703-G715. http://www.scopus.com/inward/record.url?eid=2-s2.0-84945219246&partnerID=MN8TOARS.
    10.1152/ajpgi.00124.2015
  202. Soares-da-Silva, P.; Cabral, J.M.; Magalhães, D.; Fraga, S.; Magro, F.. "Amine neurotransmitters, inflammation and epithelial sodium transport". Experimental Physiology 101 4 (2016): 459-464. http://www.scopus.com/inward/record.url?eid=2-s2.0-84950327494&partnerID=MN8TOARS.
    10.1113/EP085284
  203. Abreu, C.; Carvalho, T.; Sarmento, A.; Magro, F.. "Stool Isolation of Nocardia nova in Two Immunomodulated Patients with Inflammatory Bowel Diseases". Journal of Clinical Gastroenterology 50 1 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84951833766&partnerID=MN8TOARS.
    10.1097/MCG.0000000000000403
  204. Pereira, Cristiana; Coelho, Rosa; Grácio, Daniela; Dias, Cláudia; Silva, Marco; Peixoto, Armando; Lopes, Pedro; et al. "DNA Damage and Oxidative DNA Damage in Inflammatory Bowel Disease". (2016): http://hdl.handle.net/10400.18/4064.
    10.1093/ecco-jcc/jjw088
  205. Rieder, Florian; Latella, Giovanni; Magro, Fernando; Yuksel, Elif S.; Higgins, Peter D. R.; Di Sabatino, Antonio; de Bruyn, Jessica R.; et al. "European Crohn's and Colitis Organisation Topical Review on prediction, diagnosis and management of fibrostenosing Crohn's disease". (2016): http://hdl.handle.net/10400.1/9364.
    10.1093/ecco-jcc/jjw055
  206. Afonso, Joana; Lopes, Susana; Gonçalves, Raquel; Caldeira, Paulo; Lago, Paula; Sousa, Helena Tavares; Ramos, Jaime; et al. "Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays". (2016): http://hdl.handle.net/10400.1/9216.
    10.1177/1756283X16658223
  207. Lopes, S.; Andrade, P.; Afonso, J.; Rodrigues-Pinto, E.; Dias, C.C.; Macedo, G.; Magro, F.; et al. "Correlation between Calprotectin and Modified Rutgeerts Score". Inflammatory Bowel Diseases 22 9 (2016): 2173-2181. http://www.scopus.com/inward/record.url?eid=2-s2.0-84983627733&partnerID=MN8TOARS.
    10.1097/MIB.0000000000000850
  208. Abreu, Cândida; Santos, Lurdes; Magro, Fernando. "Varicella Complicated by Severe Pneumonia and Shock in an Immunosuppressed Crohn’s Disease Patient Under Azathioprine and Anti-Tumour Necrosis Factor Alpha: Table 1.". Journal of Crohn's and Colitis 9 12 (2015): 1176-1178. http://dx.doi.org/10.1093/ecco-jcc/jjv143.
    10.1093/ecco-jcc/jjv143
  209. Hindryckx, Pieter; Baert, Filip; Hart, Ailsa; Magro, Fernando; Armuzzi, Alessandro; Peyrin-Biroulet, Laurent; Hindryckx, P.; et al. "Clinical Trials in Ulcerative Colitis: A Historical Perspective". Journal of Crohn's and Colitis 9 7 (2015): 580-588. http://dx.doi.org/10.1093/ecco-jcc/jjv074.
    10.1093/ecco-jcc/jjv074
  210. Maconi, Giovanni; Magro, Ferdinando. "Comparing techniques to achieve high accuracy and low cost: how should we first diagnose Crohn's disease?". Journal of Comparative Effectiveness Research 4 2 (2015): 75-78. http://dx.doi.org/10.2217/cer.15.2.
    10.2217/cer.15.2
  211. Magro, Fernando; Rodrigues-Pinto, Eduardo; Coelho, Rosa; Andrade, Patrícia; Santos-Antunes, João; Lopes, Susana; Camila-Dias, Claudia; Macedo, Guilherme. "Response to Targownik". American Journal of Gastroenterology 110 2 (2015): 349-351. http://dx.doi.org/10.1038/ajg.2014.376.
    10.1038/ajg.2014.376
  212. Dias, C.C.; Rodrigues, P.P.; da Costa-Pereira, A.; Magro, F.. "Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies". Journal of Crohn's & colitis 9 2 (2015): 156-163. http://www.scopus.com/inward/record.url?eid=2-s2.0-84944246455&partnerID=MN8TOARS.
    10.1093/ecco-jcc/jju016
  213. Gonçalves, P.; Magro, F.; Martel, F.. "Metabolic inflammation in inflammatory bowel disease: Crosstalk between adipose tissue and bowel". Inflammatory Bowel Diseases 21 2 (2015): 453-467. http://www.scopus.com/inward/record.url?eid=2-s2.0-84927759781&partnerID=MN8TOARS.
    10.1097/MIB.0000000000000209
  214. Pereira, C.; Grácio, D.; Teixeira, J.P.; Magro, F.. "Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease". Inflammatory Bowel Diseases 21 10 (2015): 2403-2417. http://www.scopus.com/inward/record.url?eid=2-s2.0-84942235634&partnerID=MN8TOARS.
    10.1097/MIB.0000000000000506
  215. Magro, F.; Coelho, R.; Guimarães, L.S.; Silva, M.; Peixoto, A.; Lopes, S.; Macedo, G.. "Ionizing radiation exposure is still increasing in Crohn's disease: Who should be blamed?". Scandinavian Journal of Gastroenterology 50 10 (2015): 1214-1225. http://www.scopus.com/inward/record.url?eid=2-s2.0-84937141357&partnerID=MN8TOARS.
    10.3109/00365521.2015.1037344
  216. Abreu, C.; Rocha-Pereira, N.; Sarmento, A.; Magro, F.. "Nocardia infections among immunomodulated inflammatory bowel disease patients: A review". World Journal of Gastroenterology 21 21 (2015): 6491-6498. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930792633&partnerID=MN8TOARS.
    10.3748/wjg.v21.i21.6491
  217. van der Woude, C.J.; Ardizzone, S.; Bengtson, M.B.; Fiorino, G.; Fraser, G.; Katsanos, K.; Kolacek, S.; et al. "The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease". Journal of Crohn's & colitis 9 2 (2015): 107-124. http://www.scopus.com/inward/record.url?eid=2-s2.0-84953887240&partnerID=MN8TOARS.
  218. Dignass, A.U.; Gasche, C.; Bettenworth, D.; Birgegård, G.; Danese, S.; Gisbert, J.P.; Gomollon, F.; et al. "European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases". Journal of Crohn's & colitis 9 3 (2015): 211-222. http://www.scopus.com/inward/record.url?eid=2-s2.0-84928603336&partnerID=MN8TOARS.
    10.1093/ecco-jcc/jju009
  219. Nazareth, N.; Magro, F.; Machado, E.; Ribeiro, T.G.; Martinho, A.; Rodrigues, P.; Alves, R.; et al. "Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease". Medical Microbiology and Immunology 204 6 (2015): 681-692. http://www.scopus.com/inward/record.url?eid=2-s2.0-84942193176&partnerID=MN8TOARS.
    10.1007/s00430-015-0420-3
  220. Nazareth, N.; Magro, F.; Appelberg, R.; Silva, J.; Gracio, D.; Coelho, R.; Cabral, J.M.; et al. "Increased viability but decreased culturability of Mycobacterium avium subsp. paratuberculosis in macrophages from inflammatory bowel disease patients under Infliximab treatment". Medical Microbiology and Immunology 204 6 (2015): 647-656. http://www.scopus.com/inward/record.url?eid=2-s2.0-84942197352&partnerID=MN8TOARS.
    10.1007/s00430-015-0393-2
  221. Vegh, Z.; Burisch, J.; Pedersen, N.; Kaimakliotis, I.; Duricova, D.; Bortlik, M.; Vinding, K.K.; et al. "Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort". Journal of Crohn's & colitis 9 9 (2015): 747-753. http://www.scopus.com/inward/record.url?eid=2-s2.0-84973444990&partnerID=MN8TOARS.
    10.1093/ecco-jcc/jjv099
  222. Rodrigues, S.; Lopes, S.; Magro, F.; Cardoso, H.; Horta E Vale, A.M.; Marques, M.; Mariz, E.; et al. "Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases". World Journal of Gastroenterology 21 24 (2015): 7584-7588. http://www.scopus.com/inward/record.url?eid=2-s2.0-84936818573&partnerID=MN8TOARS.
    10.3748/wjg.v21.i24.7584
  223. Burisch, J.; Vardi, H.; Pedersen, N.; Brinar, M.; Cukovic-Cavka, S.; Kaimakliotis, I.; Duricova, D.; et al. "Costs and resource utilization for diagnosis and treatment during the initial year in a european inflammatory bowel disease inception cohort: An ECCO-EpiCom study". Inflammatory Bowel Diseases 21 1 (2015): 121-131. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925827444&partnerID=MN8TOARS.
    10.1097/MIB.0000000000000250
  224. Soares, J.-B.; Marinho, A.S.; Fernandes, D.; Moreira Gonçalves, B.; Camila-Dias, C.; Gonçalves, R.; Magro, F.. "Assessing overall patient satisfaction in inflammatory bowel disease using structural equation modeling". European Journal of Gastroenterology and Hepatology 27 8 (2015): 941-950. http://www.scopus.com/inward/record.url?eid=2-s2.0-84938497763&partnerID=MN8TOARS.
    10.1097/MEG.0000000000000385
  225. Magro, F.; Rodrigues-Pinto, E.; Coelho, R.; Andrade, P.; Santos-Antunes, J.; Lopes, S.; Camila-Dias, C.; MacEdo, G.. "Response to Irwin et al.". American Journal of Gastroenterology 110 6 (2015): 933-935. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930725184&partnerID=MN8TOARS.
    10.1038/ajg.2015.134
  226. Ruemmele, F.M.; Veres, G.; Kolho, K.L.; Griffiths, A.; Levine, A.; Escher, J.C.; Amil Dias, J.; et al. "Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease". Journal of Crohn's and Colitis 8 10 (2014): 1179-1207. http://dx.doi.org/10.1016/j.crohns.2014.04.005.
    10.1016/j.crohns.2014.04.005
  227. Santos-Antunes, João; Abreu, Cândida; Magro, Fernando; Coelho, Rosa; Vilas-Boas, Filipe; Andrade, Patrícia; Lopes, Susana; Macedo, Guilherme. "Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review". Journal of Crohn's and Colitis 8 4 (2014): 326-330. http://dx.doi.org/10.1016/j.crohns.2013.10.011.
    10.1016/j.crohns.2013.10.011
  228. Magro, Fernando; Sousa, Paula; Ministro, Paula. "C-reactive protein in Crohn’s disease: how informative is it?". Expert Review of Gastroenterology & Hepatology 8 4 (2014): 393-408. http://dx.doi.org/10.1586/17474124.2014.893821.
    10.1586/17474124.2014.893821
  229. Dignass, A.; Eliakim, R.; Magro, F.; Maaser, C.; Chowers, Y.; Geboes, K.; Mantzaris, G.; et al. "Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis | Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática Parte 1: Definiciones y diagnóstico (versión española) (Spanish version)". Revista de Gastroenterologia de Mexico 79 4 (2014): 263-289. http://www.scopus.com/inward/record.url?eid=2-s2.0-84920998730&partnerID=MN8TOARS.
    10.1016/j.rgmx.2014.10.001
  230. Magro, F.; Eliakim, R.. "Are we on our way to change our mode of thinking and treating inflammatory bowel disease patients?". Annals of Gastroenterology 27 4 (2014): 424-426. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925281488&partnerID=MN8TOARS.
  231. Fernando Magro. "Venous thrombosis and prothrombotic factors in inflammatory bowel disease". World Journal of Gastroenterology (2014): http://www.ncbi.nlm.nih.gov/pubmed/24803797.
    10.3748/wjg.v20.i17.4857
  232. Fernando Magro. "C-reactive protein in Crohn's disease: how informative is it?". Expert Rev Gastroenterol Hepatol. (2014): http://www.ncbi.nlm.nih.gov/pubmed/24635486.
    10.1586/17474124.2014.893821
  233. Fernando Magro. "Immunisations in Crohn's disease: who? why? what? when?". Best Pract Res Clin Gastroenterol. (2014): http://www.ncbi.nlm.nih.gov/pubmed/24913387.
    10.1016/j.bpg.2014.04.007
  234. Langner, C.; Magro, F.; Driessen, A.; Ensari, A.; Mantzaris, G.J.; Villanacci, V.; Becheanu, G.; et al. "The histopathological approach to inflammatory bowel disease: A practice guide". Virchows Archiv 464 5 (2014): 511-527. http://www.scopus.com/inward/record.url?eid=2-s2.0-84902344429&partnerID=MN8TOARS.
    10.1007/s00428-014-1543-4
  235. Rahier, J.F.; Magro, F.; Abreu, C.; Armuzzi, A.; Ben-Horin, S.; Chowers, Y.; Cottone, M.; et al. "Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease". Journal of Crohn's and Colitis 8 6 (2014): 443-468. http://www.scopus.com/inward/record.url?eid=2-s2.0-84899719594&partnerID=MN8TOARS.
    10.1016/j.crohns.2013.12.013
  236. Rieder, F.; de Bruyn, J.R.; Pham, B.T.; Katsanos, K.; Annese, V.; Higgins, P.D.R.; Magro, F.; Dotan, I.. "Results of the 4th Scientific Workshop of the ECCO (Group II): Markers of intestinal fibrosis in inflammatory bowel disease". Journal of Crohn's and Colitis 8 10 (2014): 1166-1178. http://www.scopus.com/inward/record.url?eid=2-s2.0-84908227294&partnerID=MN8TOARS.
    10.1016/j.crohns.2014.03.009
  237. Rodrigues-Pinto, E.; Magro, F.; Pimenta, S.; Guimarães, J.; Macedo, G.. "Mimicry between intestinal Behçet's disease and inflammatory bowel disease". Journal of Crohn's and Colitis 8 7 (2014): 714-715. http://www.scopus.com/inward/record.url?eid=2-s2.0-84901507323&partnerID=MN8TOARS.
    10.1016/j.crohns.2013.12.009
  238. Santos-Antunes, J.; Magro, F.; Macedo, G.. "Listeria monocytogenes bacteremia and CMV colitis in a patient with Ulcerative Colitis". Journal of Crohn's and Colitis 8 3 (2014): 254-255. http://www.scopus.com/inward/record.url?eid=2-s2.0-84894227199&partnerID=MN8TOARS.
    10.1016/j.crohns.2013.10.003
  239. Magro, F.; Rodrigues-Pinto, E.; Coelho, R.; Andrade, P.; Santos-Antunes, J.; Lopes, S.; Camila-Dias, C.; MacEdo, G.. "Is it possible to change phenotype progression in crohn's disease in the era of immunomodulators? predictive factors of phenotype progression". American Journal of Gastroenterology 109 7 (2014): 1026-1036. http://www.scopus.com/inward/record.url?eid=2-s2.0-84903900714&partnerID=MN8TOARS.
    10.1038/ajg.2014.97
  240. Magro, F.; Peyrin-Biroulet, L.; Sokol, H.; Aldeger, X.; Costa, A.; Higgins, P.D.; Joyce, J.C.; et al. "Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III)". Journal of Crohn's and Colitis 8 1 (2014): 31-44. http://www.scopus.com/inward/record.url?eid=2-s2.0-84890117256&partnerID=MN8TOARS.
    10.1016/j.crohns.2013.04.006
  241. Oresland, T.; Bemelman, W.; Sampietro, G.; Spinelli, A.; Windsor, A.; Tiret, E.; Sica, G.; et al. "European evidence based consensus on surgery for ulcerative colitis". Journal of Crohn's and Colitis (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84908472168&partnerID=MN8TOARS.
    10.1016/j.crohns.2014.08.012
  242. Burisch, J.; Pedersen, N.; Cukovic-Cavka, S.; Turk, N.; Kaimakliotis, I.; Duricova, D.; Bortlik, M.; et al. "Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe - An ECCO-EpiCom study". Journal of Crohn's and Colitis 8 7 (2014): 607-616. http://www.scopus.com/inward/record.url?eid=2-s2.0-84901508464&partnerID=MN8TOARS.
    10.1016/j.crohns.2013.11.021
  243. Fernando Magro. "Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection.". Clin Exp Immunol. (2014): http://www.ncbi.nlm.nih.gov/pubmed/?term=Infliximab+therapy+increases+the+frequency+of+circulating+CD16%2B+monocytes+and+modifies+macrophage+cytokine+response+to+bacterial+infection.
    10.1111/cei.12375
  244. Burisch, J.; Pedersen, N.; Cukovic-Cavka, S.; Brinar, M.; Kaimakliotis, I.; Duricova, D.; Shonová, O.; et al. "East-West gradient in the incidence of inflammatory bowel disease in Europe: The ECCO-EpiCom inception cohort". Gut 63 4 (2014): 588-597. http://www.scopus.com/inward/record.url?eid=2-s2.0-84895498341&partnerID=MN8TOARS.
    10.1136/gutjnl-2013-304636
  245. Magro, F.; Rodrigues-Pinto, E.; Lopes, S.; Macedo, G.. "Earlier need of infliximabintensification in Ulcerative Colitisthan in Crohn's disease". Journal of Crohn's and Colitis 8 10 (2014): 1331-1332. http://www.scopus.com/inward/record.url?eid=2-s2.0-84908237008&partnerID=MN8TOARS.
    10.1016/j.crohns.2014.03.007
  246. Santos-Antunes, J.; Abreu, C.; Magro, F.; Coelho, R.; Vilas-Boas, F.; Andrade, P.; Lopes, S.; Macedo, G.. "Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review". Journal of Crohn's and Colitis 8 4 (2014): 326-330. http://www.scopus.com/inward/record.url?eid=2-s2.0-84895498729&partnerID=MN8TOARS.
    10.1016/j.crohns.2013.10.011
  247. Magro, F.; Santos-Antunes, J.; Vilas-Boas, F.; Rodrigues-Pinto, E.; Coelho, R.; Ribeiro, O.S.; Lopes, S.; Macedo, G.. "Crohn's disease outcome in patients under azathioprine: A tertiary referral center experience". Journal of Crohn's and Colitis 8 7 (2014): 617-625. http://www.scopus.com/inward/record.url?eid=2-s2.0-84901490124&partnerID=MN8TOARS.
    10.1016/j.crohns.2013.11.020
  248. Burisch, J.; Pedersen, N.; Cukovic-Cavka, S.; Turk, N.; Kaimakliotis, I.; Duricova, D.; Shonová, O.; et al. "Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: The ECCO-EpiCom cohort". Inflammatory Bowel Diseases 20 1 (2014): 36-46. http://www.scopus.com/inward/record.url?eid=2-s2.0-84893671655&partnerID=MN8TOARS.
    10.1097/01.MIB.0000436277.13917.c4
  249. Vegh, Z.; Burisch, J.; Pedersen, N.; Kaimakliotis, I.; Duricova, D.; Bortlik, M.; Avnstrøm, S.; et al. "Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohort". Journal of Crohn's and Colitis 8 11 (2014): 1506-1515. http://www.scopus.com/inward/record.url?eid=2-s2.0-84927786121&partnerID=MN8TOARS.
    10.1016/j.crohns.2014.06.004
  250. Eliakim, R.; Magro, F.. "Imaging techniques in IBD and their role in follow-up and surveillance". Nature Reviews Gastroenterology and Hepatology (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84906302268&partnerID=MN8TOARS.
    10.1038/nrgastro.2014.144
  251. Magro, F.; Rodrigues-Pinto, E.; Santos-Antunes, J.; Vilas-Boas, F.; Lopes, S.; Nunes, A.; Camila-Dias, C.; Macedo, G.. "High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment". Journal of Crohn's and Colitis 8 2 (2014): 129-136. http://www.scopus.com/inward/record.url?eid=2-s2.0-84892844317&partnerID=MN8TOARS.
    10.1016/j.crohns.2013.07.005
  252. Burisch, J.; Weimers, P.; Pedersen, N.; Cukovic-Cavka, S.; Vucelic, B.; Kaimakliotis, I.; Duricova, D.; et al. "Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease - An ECCO-EpiCom study". Journal of Crohn's and Colitis 8 9 (2014): 1030-1042. http://www.scopus.com/inward/record.url?eid=2-s2.0-84906791641&partnerID=MN8TOARS.
    10.1016/j.crohns.2014.01.028
  253. Burisch, J.; Vegh, Z.; Pedersen, N.; Cukovic-Cavka, S.; Turk, N.; Kaimakliotis, I.; Duricova, D.; et al. "Health care and patients' education in a European inflammatory bowel disease inception cohort: An ECCO-EpiCom study". Journal of Crohn's and Colitis 8 8 (2014): 811-818. http://www.scopus.com/inward/record.url?eid=2-s2.0-84904509208&partnerID=MN8TOARS.
    10.1016/j.crohns.2013.12.023
  254. Dias, C.C.; Rodrigues, P.P.; da Costa-Pereira, A.; Magro, F.. "Clinical prognostic factors for disabling Crohn's disease: A systematic review and meta-analysis". World Journal of Gastroenterology 19 24 (2013): 3866-3871. http://www.scopus.com/inward/record.url?eid=2-s2.0-84879583870&partnerID=MN8TOARS.
    10.3748/wjg.v19.i24.3866
  255. Stein, J.; Bager, P.; Befrits, R.; Gasche, C.; Gudehus, M.; Lerebours, E.; Magro, F.; et al. "Anaemia management in patients with inflammatory bowel disease: Routine practice across nine European countries". European Journal of Gastroenterology and Hepatology 25 12 (2013): 1456-1463. http://www.scopus.com/inward/record.url?eid=2-s2.0-84887051883&partnerID=MN8TOARS.
    10.1097/MEG.0b013e328365ca7f
  256. Abreu, C.; Magro, F.; Santos-Antunes, J.; Pilão, A.; Rodrigues-Pinto, E.; Bernardes, J.; Bernardo, A.; et al. "Tuberculosis in anti-TNF-a treated patients remains a problem in countries with an intermediate incidence: Analysis of 25 patients matched with a control population". Journal of Crohn's and Colitis 7 10 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84884133830&partnerID=MN8TOARS.
    10.1016/j.crohns.2013.03.004
  257. Cabral, J.M.; Soares-Da-Silva, P.; Magro, F.. "Short- and long-term regulation of intestinal Na+/H+ exchange activity associated with TLR2 receptor activation is independent of nuclear factor-¿b signaling". Journal of Pharmacology and Experimental Therapeutics 346 3 (2013): 453-464. http://www.scopus.com/inward/record.url?eid=2-s2.0-84882421561&partnerID=MN8TOARS.
    10.1124/jpet.113.204602
  258. Durães, C.; Machado, J.C.; Portela, F.; Rodrigues, S.; Lago, P.; Cravo, M.; Ministro, P.; et al. "Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA Study II)". Inflammatory Bowel Diseases 19 2 (2013): 230-239. http://www.scopus.com/inward/record.url?eid=2-s2.0-84876411425&partnerID=MN8TOARS.
    10.1002/ibd.23007
  259. Abreu, C.; Magro, F.; Vilas-Boas, F.; Lopes, S.; Macedo, G.; Sarmento, A.. "Listeria infection in patients on anti-TNF treatment: Report of two cases and review of the literature". Journal of Crohn's and Colitis 7 2 (2013): 175-182. http://www.scopus.com/inward/record.url?eid=2-s2.0-84872446029&partnerID=MN8TOARS.
    10.1016/j.crohns.2012.04.018
  260. Costa, J.; Magro, F.; Caldeira, D.; Alarcão, J.; Sousa, R.; Vaz-Carneiro, A.. "Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: A systematic review and meta-analysis". Inflammatory Bowel Diseases 19 10 (2013): 2098-2110. http://www.scopus.com/inward/record.url?eid=2-s2.0-84884577666&partnerID=MN8TOARS.
    10.1097/MIB.0b013e31829936c2
  261. Panes, J.; Bouhnik, Y.; Reinisch, W.; Stoker, J.; Taylor, S.A.; Baumgart, D.C.; Danese, S.; et al. "Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines". Journal of Crohn's and Colitis 7 7 (2013): 556-585. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878643775&partnerID=MN8TOARS.
    10.1016/j.crohns.2013.02.020
  262. Magro, F.; Langner, C.; Driessen, A.; Ensari, A.; Geboes, K.; Mantzaris, G.J.; Villanacci, V.; et al. "European consensus on the histopathology of inflammatory bowel disease". Journal of Crohn's and Colitis 7 10 (2013): 827-851. http://www.scopus.com/inward/record.url?eid=2-s2.0-84884175393&partnerID=MN8TOARS.
    10.1016/j.crohns.2013.06.001
  263. Magro, F.; Santos-Antunes, J.; Albuquerque, A.; Vilas-Boas, F.; Macedo, G.N.; Nazareth, N.; Lopes, S.; et al. "Epstein-barr virus in inflammatory bowel disease-correlation with different therapeutic regimens". Inflammatory Bowel Diseases 19 8 (2013): 1710-1716. http://www.scopus.com/inward/record.url?eid=2-s2.0-84884550522&partnerID=MN8TOARS.
    10.1097/MIB.0b013e318281f31c
  264. Dignass, A.; Eliakim, R.; Magro, F.; Maaser, C.; Chowers, Y.; Geboes, K.; Mantzaris, G.; et al. "Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis". Journal of Crohn's and Colitis 6 10 (2012): 965-990. http://www.scopus.com/inward/record.url?eid=2-s2.0-84869083669&partnerID=MN8TOARS.
    10.1016/j.crohns.2012.09.003
  265. Magro, F.; Rodrigues, A.; Vieira, A.I.; Portela, F.; Cremers, I.; Cotter, J.; Correia, L.; et al. "Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts". Inflammatory Bowel Diseases 18 3 (2012): 573-583. http://www.scopus.com/inward/record.url?eid=2-s2.0-84857356639&partnerID=MN8TOARS.
    10.1002/ibd.21815
  266. Vilas-Boas, F.; Magro, F.; Balhau, R.; Lopes, J.M.; Beça, F.; Eloy, C.; Lopes, S.; Macedo, G.. "Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: Case report and review of the literature". Journal of Crohn's and Colitis 6 7 (2012): 792-795. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863440903&partnerID=MN8TOARS.
    10.1016/j.crohns.2012.03.004
  267. Osório, F.; Magro, F.; Lisboa, C.; Lopes, S.; MacEdo, G.; Bettencourt, H.; Azevedo, F.; Magina, S.. "Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: Report of five cases and review of the literature". Dermatology 225 2 (2012): 163-167. http://www.scopus.com/inward/record.url?eid=2-s2.0-84870812558&partnerID=MN8TOARS.
    10.1159/000342503
  268. Magro,Fernando; Correia,Luis; Lago,Paula; Macedo,Guilherme; Peixe,Paula; Portela,Francisco; Dias,Jorge Amil; et al. "Decisões clínicas na doença de Crohn". (2012): http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-81782012000200005.
  269. Magro,Fernando; Cravo,Marilia; Lago,Paula; Ministro,Paula; Peixe,Paula; Portela,Francisco; Ramos,Jaime; Tavares,Lourdes. "Portuguese consensus on the best practice for the management of inflammatory bowel disease: IBD ahead 2010 meeting results". (2012): http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-81782012000400005.
  270. Peyrin-Biroulet, L.; Ferrante, M.; Magro, F.; Campbell, S.; Franchimont, D.; Fidder, H.; Strid, H.; et al. "Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease". Journal of Crohn's and Colitis 5 5 (2011): 477-483. http://www.scopus.com/inward/record.url?eid=2-s2.0-80053133374&partnerID=MN8TOARS.
    10.1016/j.crohns.2011.06.009
  271. Albuquerque, A.; Magro, F.; Rodrigues, S.; Lopes, J.; Lopes, S.; Dias, J.M.; Carneiro, F.; MacEdo, G.. "Metastatic cutaneous Crohn's disease of the face: A case report and review of the literature". European Journal of Gastroenterology and Hepatology 23 10 (2011): 954-956. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052685788&partnerID=MN8TOARS.
    10.1097/MEG.0b013e328348d706
  272. Campos, N.; Magro, F.; Castro, A.R.; Cabral, J.; Rodrigues, P.; Silva, R.; Appelberg, R.; et al. "Macrophages from IBD patients exhibit defective tumour necrosis factor-a secretion but otherwise normal or augmented pro-inflammatory responses to infection". Immunobiology 216 8 (2011): 961-970. http://www.scopus.com/inward/record.url?eid=2-s2.0-79959492512&partnerID=MN8TOARS.
    10.1016/j.imbio.2011.01.002
  273. Albuquerque, A.; Magro, F.; Rodrigues, S.; Lopes, S.; Pereira, P.; Melo, R.B.; Madureira, M.; Macedo, G.. "Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: First case report". Journal of Crohn's and Colitis 5 4 (2011): 360-363. http://www.scopus.com/inward/record.url?eid=2-s2.0-79958830532&partnerID=MN8TOARS.
    10.1016/j.crohns.2011.02.012
  274. Magro, F.; Lopes, S.; Rodrigues, S.; Azevedo, I.. "How to manage pouchitis in ulcerative colitis?". Current Drug Targets 12 10 (2011): 1454-1461. http://www.scopus.com/inward/record.url?eid=2-s2.0-80051699225&partnerID=MN8TOARS.
    10.2174/138945011796818144
  275. Rodrigues, S.; Pereira, P.; Magro, F.; Lopes, S.; Albuquerque, A.; Lopes, J.; Carneiro, F.; Macedo, G.. "Dysplasia surveillance in an ulcerative colitis patient: Successful detection with Narrow band imaging and magnification". Journal of Crohn's and Colitis 5 1 (2011): 54-56. http://www.scopus.com/inward/record.url?eid=2-s2.0-78951471692&partnerID=MN8TOARS.
    10.1016/j.crohns.2010.08.005
  276. Burisch, J.; Cukovic-Cavka, S.; Kaimakliotis, I.; Shonová, O.; Andersen, V.; Dahlerup, J.F.; Elkjaer, M.; et al. "Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe. An EpiCom study". Journal of Crohn's and Colitis 5 4 (2011): 342-349. http://www.scopus.com/inward/record.url?eid=2-s2.0-79958839810&partnerID=MN8TOARS.
    10.1016/j.crohns.2011.02.016
  277. Ferreira,Frederico; Albuquerque,Andreia; Rodrigues,Susana; Pereira,Pedro; Magro,Fernando; Macedo,Guilherme. "Megacólon Tóxico como Manifestação Inaugural de Colite Ulcerosa". (2011): http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-81782011000400008.
  278. Magro,Fernando; Benito-Garcia,Elisabete; Cremers,Isabelle; Correia,Luís; Cotter,José; Duarte,Maria Antónia; Lago,Paula; et al. "Terapêutica de Manutenção da Remissão na Colite Ulcerosa Moderada a Grave". (2011): http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-81782011000400004.
  279. Magro, Fernando; Portela, Francisco. "Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies". BioDrugs 24 (2010): 3-14. http://dx.doi.org/10.2165/11586290-000000000-00000.
    10.2165/11586290-000000000-00000
  280. Marques, M.; Rodrigues, S.; Mariz, E.; Pinto, J.; Videira, T.; Brito, J.; Reis, C.; Simões-Ventura, F.; Magro, F.. "Severe gram positive bacterial infection in an ulcerative colitis patient treated with Infliximab". Journal of Crohn's and Colitis 4 1 (2010): 110-113. http://www.scopus.com/inward/record.url?eid=2-s2.0-75149139786&partnerID=MN8TOARS.
    10.1016/j.crohns.2009.08.005
  281. Magro, F.; Portela, F.. "Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor therapies. Foreword.". BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 24 Suppl 1 SUPPL. 1 (2010): 1-2. http://www.scopus.com/inward/record.url?eid=2-s2.0-84855503673&partnerID=MN8TOARS.
    10.2165/11586290-000000000-00000
  282. Azevedo, L.F.; Magro, F.; Portela, F.; Lago, P.; Deus, J.; Cotter, J.; Cremers, I.; et al. "Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approach". Pharmacoepidemiology and Drug Safety 19 5 (2010): 499-510. http://www.scopus.com/inward/record.url?eid=2-s2.0-77952782323&partnerID=MN8TOARS.
    10.1002/pds.1930
  283. Magro, F.; Barreiro-de Acosta, M.; Lago, P.; Carpio, D.; Cotter, J.; Echarri, A.; Gonçalves, R.; et al. "Clinical practice in Crohn's disease in bordering regions of two countries: Different medical options, distinct surgical events". Journal of Crohn's and Colitis 4 3 (2010): 301-311. http://www.scopus.com/inward/record.url?eid=2-s2.0-77955281840&partnerID=MN8TOARS.
    10.1016/j.crohns.2009.12.004
  284. Rodrigues, S.; Magro, F.; Soares, J.; Nunes, A.C.R.; Lopes, S.; Marques, M.; Rio, E.; MacEdo, G.. "Case series: Ulcerative colitis, multiple sclerosis, and interferon-beta 1a". Inflammatory Bowel Diseases 16 12 (2010): 2001-2003. http://www.scopus.com/inward/record.url?eid=2-s2.0-78649562507&partnerID=MN8TOARS.
    10.1002/ibd.21242
  285. Magro, F.. "BioDrugs: Foreword". BioDrugs 24 SUPPL. 1 (2010): 1-2. http://www.scopus.com/inward/record.url?eid=2-s2.0-78650437168&partnerID=MN8TOARS.
  286. Barreiro-De Acosta, M.; Magro, F.; Carpio, D.; Lago, P.; Echarri, A.; Cotter, J.; Pereira, S.; et al. "Ulcerative colitis in northern Portugal and Galicia in Spain". Inflammatory Bowel Diseases 16 7 (2010): 1227-1238. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953717409&partnerID=MN8TOARS.
    10.1002/ibd.21170
  287. Portela, F.; Magro, F.; Lago, P.; Cotter, J.; Cremers, I.; De Deus, J.; Vieira, A.; et al. "Ulcerative colitis in a southern european country: A national perspective". Inflammatory Bowel Diseases 16 5 (2010): 822-829. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950651609&partnerID=MN8TOARS.
    10.1002/ibd.21119
  288. Martinho, António; Campos, Nair; Rodrigues, Pedro; Magro, Fernando; Sarmento, Amélia. "Mycobacterium avium subsp paratuberculosis detection from blood of Crohn's disease patients in a portuguese hospital". (2010): http://hdl.handle.net/10284/2995.
  289. Pimentel-Nunes, P.; Dinis-Ribeiro, M.; Magro, F.. "Systematic review on drug and diet-induced endoscopic remission in Crohn's disease". European Journal of Gastroenterology and Hepatology 21 5 (2009): 491-503. http://www.scopus.com/inward/record.url?eid=2-s2.0-67651172838&partnerID=MN8TOARS.
    10.1097/MEG.0b013e3283196b03
  290. Magro, F.; Portela, F.; Lago, P.; Deus, J.; Cotter, J.; Cremers, I.; Vieira, A.; et al. "Inflammatory bowel disease: A patient's and caregiver's perspective". Digestive Diseases and Sciences 54 12 (2009): 2671-2679. http://www.scopus.com/inward/record.url?eid=2-s2.0-70450231939&partnerID=MN8TOARS.
    10.1007/s10620-008-0658-3
  291. Baeten, D.; van Hagen, M.; Magro, F.; Filipe, P.; Fonseca, J.E.. "Immune - mediated inflammatory diseases: A new multidisciplinary concept". Acta Reumatologica Portuguesa 34 3 (2009): 457-459. http://www.scopus.com/inward/record.url?eid=2-s2.0-72449170518&partnerID=MN8TOARS.
  292. Magro, F.; Portela, F.; Lago, P.; De Deus, J.R.; Vieira, A.; Peixe, P.; Cremers, I.; et al. "Crohn's disease in a Southern European country: Montreal classification and clinical activity". Inflammatory Bowel Diseases 15 9 (2009): 1343-1350. http://www.scopus.com/inward/record.url?eid=2-s2.0-70449698214&partnerID=MN8TOARS.
    10.1002/ibd.20901
  293. Campos, Nair; Castro, Ana Rita; Cabral, Joana; Bacalhau, Nicole Marques; Magro, Fernando; Sarmento, Amélia. "Mycobacterium avium SPP. Paratuberculosis up-regulates CD40 expression and down-regulates IL-10 production by human macrophages". (2009): http://hdl.handle.net/10284/1266.
  294. Marques, M.; Magro, F.; Cardoso, H.; Carneiro, F.; Portugal, R.; Lopes, J.; Costa Santos, C.. "Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis". Inflammatory Bowel Diseases 14 5 (2008): 723-725. http://www.scopus.com/inward/record.url?eid=2-s2.0-44349107627&partnerID=MN8TOARS.
    10.1002/ibd.20293
  295. Magro, F.; Bastos, R.; Marques, M.; Costa Santos, C.. "Infliximab dose intensification by shortening infusion intervals". Inflammatory Bowel Diseases 14 3 (2008): 432-434. http://www.scopus.com/inward/record.url?eid=2-s2.0-41149170747&partnerID=MN8TOARS.
    10.1002/ibd.20314
  296. Magro, F.; Marques, M.; Santos, C.C.. "Episodic infliximab treatment induces infusion reactions". Inflammatory Bowel Diseases 14 11 (2008): 1608-1610. http://www.scopus.com/inward/record.url?eid=2-s2.0-59249093415&partnerID=MN8TOARS.
    10.1002/ibd.20476
  297. Magro, F.; Fraga, S.; Soares-da-Silva, P.. "Short-term effect on intestinal epithelial Na+/H+ exchanger by Gia1,2-coupled 5-HT1A and Gq/11-coupled 5-HT2 receptors". Life Sciences 81 7 (2007): 560-569. http://www.scopus.com/inward/record.url?eid=2-s2.0-34547677743&partnerID=MN8TOARS.
    10.1016/j.lfs.2007.06.024
  298. Magro,Fernando. "Reflexões sobre a etiopatogenia". (2007): http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-81782007000200006.
  299. Magro, F.; Fraga, S.; Azevedo, I.; Soares-Da-Silva, P.. "Intestinal 5-hydroxytryptamine and mast cell infiltration in rat experimental colitis". Digestive Diseases and Sciences 51 3 (2006): 495-501. http://www.scopus.com/inward/record.url?eid=2-s2.0-33645874190&partnerID=MN8TOARS.
    10.1007/s10620-006-3161-8
  300. Magro, F.; Cunha, E.; Araujo, F.; Meireles, E.; Pereira, P.; Dinis-Ribeiro, M.; Veloso, F.T.; Medeiros, R.; Soares-Da-Silva, P.. "Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment". Digestive Diseases and Sciences 51 11 (2006): 2039-2044. http://www.scopus.com/inward/record.url?eid=2-s2.0-33751531923&partnerID=MN8TOARS.
    10.1007/s10620-006-9168-3
  301. Magro, F.; Costa, C.. "Long-standing remission of Crohn's disease under imatinib therapy in a patient with Crohn's disease [1]". Inflammatory Bowel Diseases 12 11 (2006): 1087-1089. http://www.scopus.com/inward/record.url?eid=2-s2.0-33750514598&partnerID=MN8TOARS.
    10.1097/01.mib.0000232468.15950.34
  302. Magro, F.; Pereira, P.; Tavarela Veloso, F.; Carneiro, F.. "Unusual presentation of tuberculosis after infliximab therapy [4]". Inflammatory Bowel Diseases 11 1 (2005): 82-84. http://www.scopus.com/inward/record.url?eid=2-s2.0-13944250654&partnerID=MN8TOARS.
    10.1097/00054725-200501000-00017
  303. Magro, F.; Fraga, S.; Soares-Da-Silva, P.. "Signaling of short- and long-term regulation of intestinal epithelial type 1 Na +/H + exchanger by interferon-¿". British Journal of Pharmacology 145 1 (2005): 93-103. http://www.scopus.com/inward/record.url?eid=2-s2.0-18744371031&partnerID=MN8TOARS.
    10.1038/sj.bjp.0706167
  304. Magro, F.; Fraga, S.; Ribeiro, T.; Soares-Da-Silva, P.. "Regional intestinal adaptations in Na+,K+-ATPase in experimental colitis and the contrasting effects of interferon-¿". Acta Physiologica Scandinavica 183 2 (2005): 191-199. http://www.scopus.com/inward/record.url?eid=2-s2.0-13444291854&partnerID=MN8TOARS.
    10.1111/j.1365-201X.2004.01388.x
  305. Magro, F.; Pereira, P.; Carneiro, F.; Tavarela Veloso, F.. "Reactive hepatitis in a patient with Crohn's disease succcessfully treated with infliximab: Does tumor necrosis factor alpha play a role in reactive hepatitis? [8]". Inflammatory Bowel Diseases 11 1 (2005): 88-90. http://www.scopus.com/inward/record.url?eid=2-s2.0-13944265036&partnerID=MN8TOARS.
    10.1097/00054725-200501000-00021
  306. Magro, F.; Fraga, S.; Soares-da-Silva, P.. "Interferon-¿-induced STAT1-mediated membrane retention of NHE1 and associated proteins ezrin, radixin and moesin in HT-29 cells". Biochemical Pharmacology 70 9 (2005): 1312-1319. http://www.scopus.com/inward/record.url?eid=2-s2.0-25644446715&partnerID=MN8TOARS.
    10.1016/j.bcp.2005.07.015
  307. Mergulhão, P.; Magro, F.; Pereira, P.; Correia, R.; Lopes, J.M.; Magalhães, J.; Dias, J.M.; Carneiro, F.; Tavarela-Veloso, F.. "Gingival hyperplasia as a first manifestation of Crohn's disease". Digestive Diseases and Sciences 50 10 (2005): 1946-1949. http://www.scopus.com/inward/record.url?eid=2-s2.0-26244465342&partnerID=MN8TOARS.
    10.1007/s10620-005-2965-2
  308. Magro, F.; Pereira, P.; Carneiro, F.; Lopes, J.M.; Teixeira, A.; Sarmento, C.; Lima, J.; Saraiva, A.; Tavarela-Veloso, F.. "Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneum". Scandinavian Journal of Gastroenterology 40 10 (2005): 1251-1254. http://www.scopus.com/inward/record.url?eid=2-s2.0-27144487009&partnerID=MN8TOARS.
    10.1080/00365520510023323
  309. Magro, F.; Araujo, F.; Pereira, P.; Meireles, E.; Diniz-Ribeiro, M.; Velosom, F.T.. "Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease". Digestive Diseases and Sciences 49 7-8 (2004): 1265-1274. http://www.scopus.com/inward/record.url?eid=2-s2.0-4444255941&partnerID=MN8TOARS.
    10.1023/B:DDAS.0000037822.55717.31
  310. Magro, F.; Fraga, S.; Ribeiro, T.; Soares-Da-Silva, P.. "Intestinal Na +-K +-ATPase activity and molecular events downstream of interferon-¿ receptor stimulation". British Journal of Pharmacology 142 8 (2004): 1281-1292. http://www.scopus.com/inward/record.url?eid=2-s2.0-4444376321&partnerID=MN8TOARS.
    10.1038/sj.bjp.0705895
  311. Magro, F.; Fraga, S.; Ribeiro, T.; Soares-da-Silva, P.. "Decreased availability of intestinal dopamine in transmural colitis may relate to inhibitory effects of interferon-¿ upon L-DOPA uptake". Acta Physiologica Scandinavica 180 4 (2004): 379-386. http://www.scopus.com/inward/record.url?eid=2-s2.0-1942534113&partnerID=MN8TOARS.
    10.1111/j.1365-201X.2004.01260.x
  312. Magro, F.; Dinis-Ribeiro, M.; Araújo, F.M.; Pereira, P.; Fraga, M.C.; Cunha-Ribeiro, L.M.; Tomé-Ribeiro, A.. "High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease". European Journal of Gastroenterology and Hepatology 15 11 (2003): 1157-1163. http://www.scopus.com/inward/record.url?eid=2-s2.0-0842265263&partnerID=MN8TOARS.
    10.1097/00042737-200311000-00002
  313. Magro, F.; Vieira-Coelho, M.A.; Fraga, S.; Serräo, M.P.; Veloso, F.T.; Ribeiro, T.; Soares-da-Silva, P.. "Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease". Digestive Diseases and Sciences 47 1 (2002): 216-224. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036149120&partnerID=MN8TOARS.
    10.1023/A:1013256629600
  314. Magro, F.; Correia, M.; Moreira, G.; Dinis-Ribeiro, M.; Amandio, V.; Carneiro, F.; Ribeiro, T.. "Adenocarcinoma of the cecum as the first manifestation of ulcerative colitis complicated by primary sclerosing cholangitis and endomyocardial fibrosis". Inflammatory Bowel Diseases 8 4 (2002): 287-290. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036063946&partnerID=MN8TOARS.
  315. Veloso, F.T.; Carvalho, J.; Magro, F.. "Immune-related systemic manifestations of inflammatory bowel disease: A prospective study of 792 patients". Journal of Clinical Gastroenterology 23 1 (1996): 29-34. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030016118&partnerID=MN8TOARS.
    10.1097/00004836-199607000-00009
  316. Magro, F.; Paiva, J.A.. "Refractory or recurrent Hodgkin's disease: How to manage it? | DOENCA DE HODGKIN REFRACTARIA OU EM RECAIDA: COMO CURAR?". Arquivos de Medicina 7 3 (1993): 180-186. http://www.scopus.com/inward/record.url?eid=2-s2.0-0027259461&partnerID=MN8TOARS.
Report
  1. Ferreira,Frederico; Cardoso,Helder; Albuquerque,Andreia; Magro,Fernando; Macedo,Guilherme. 2012. Whipple¿s disease and giardiasis: An uncommon association. http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-81782012000400010.

Other

Other output
  1. Da Classificação de Viena para a Nova Classificação de Montreal. 2011. Magro,Fernando. http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-81782011000200012.
  2. A evidência dever-se-á sobrepor à convicção. 2011. Magro,Fernando. http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-81782011000500010.
  3. Diarreia Associada a Clostridium Difficile: um Problema Actual. 2010. Magro,Fernando. http://www.scielo.mec.pt/scielo.php?script=sci_arttext&pid=S0872-81782010000100002.
Activities

Supervision

Thesis Title
Role
Degree Subject (Type)
Institution / Organization
2020/09 - Current Assessing the translational potential of dipeptidyl peptidase 4 and gut microbiome as biomarkers of inflammatory bowel disease
Supervisor of Sandra F. Gomes
Programa Doutoral em Farmacologia e Toxicologia Experimentais e Clínicas (PhD)
Universidade do Porto Faculdade de Medicina, Portugal

Universidade do Porto Centro de Investigação Farmacológica e Inovação Medicamentosa, Portugal
2020/01/01 - Current Exploring the RAS-independente roles of ACE2 as new biomarkers in inflammatory bowel disease
Co-supervisor
Farmacologia e Toxicologia Experimentais e Clínicas (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2020/01 - Current Study of effectiveness, safety and economic impact of innovative medicines using hospital real-world data
Co-supervisor
Programa Doutoral em Ciência de Dados de Saúde (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2020/01 - Current Ulceration of Crohn's post-surgery anastomosis – "new syndrome”
Supervisor
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2017/09 - Current Burden of Inflammatory Bowel Disease in Portugal
Supervisor
Programa Doutoral em Investigação Clínica e em Serviços de Saúde (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2011 - Current O papel Glucagon-like Peptide-2 e da Dipeptidit Peptidase 4/CD26 na doença de Crohn
Supervisor
Medicina e Oncologia Molecular (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2017/01 - 2019 Pharmacological interventions upon ion sensing and transport mechanisms in fibrotic Crohn´s disease
Supervisor
Farmacologia e Toxicologia Experimentais e Clínicas (associação) (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2017/01 - 2019 Thiopurines and metabolites: pharmacokinetic and inflammatory implications
Supervisor
Farmacologia e Toxicologia Experimentais e Clínicas (associação) (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2013/01 - 2018/01 Infeção e Imunomodulação
Co-supervisor
Programa Doutoral em Medicina e Oncologia Molecular (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2018/01 - 2018 A systematic review and meta-analysis on 6-thioguanine nucleotides levels and clinical remission in inflammatory bowel disease
Supervisor
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2012/01 - 2017/01 Regulatory effects of pattern recognition receptors (PRRs) in electrolyte transport and membrane potential in intestinal epithelial cells.
Supervisor
Metabolismo - Clínica e Experimentação (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2017/01 - 2017 A systematic review on infliximab and adalimumab drug monitoring: levels, clinical outcomes and assays
Supervisor
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2017/01 - 2017 Role of epithelial ion transports in inflammatory bowel disease
Supervisor
Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2017/01 - 2017 Anti-Drug Antibodies in the therapeutic response of IBD patients
Supervisor
Ciências e Tecnologias da Saúde (PhD)
Universidade de Lisboa Faculdade de Medicina, Portugal
2011 - 2017 Oxidative stress and DNA damage - contributions to Inflammatory Bowel Disease
Supervisor
Metabolismo - Clínica e Experimentação (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2014/01 - 2016 Therapeutic Drug Monitoring: An Emergent Approach in Inflammatory Bowel Disease
Supervisor
Farmacologia e Toxicologia Experimentais e Clínicas (associação) (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2010/01 - 2014/01 Macrophage-Mycobacterium avium subsp. paratuberculosis interplay in inflammatory bowel disease: Possible immunopathological implications
Co-supervisor
Programa Doutoral em Metabolismo - Clínica e Experimentação (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2012/01 - 2014 Prognostic models for Inflammatory Bowel Disease: evidence, classification and prediction
Supervisor
Investigação Clínica e em Serviços de Saúde (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2011 - 2014 Contributo da endoscopia, biomarcadores e imagiologia na evolução clinica dos doentes com doença inflamatória intestinal
Supervisor
Medicina (PhD)
Universidade do Porto Faculdade de Medicina, Portugal

Jury of academic degree

Topic
Role
Candidate name (Type of degree)
Institution / Organization
2020/08 A eficácia do tratamento psicofarmacológico e psicoterapia nas Doenças Inflamatórias Intestinais Pedro Alexandre de Sousa Silva (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2020/01 Modelling Propofol pharmacokinetics and pharmacodynamics during an intravenous anaesthesia guided by the bispectral index (Bis)
Thesis Member
Ana Maria Faria Araújo (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2019/06 Effects of salt-inducible kinase 1 (SIK1) ablation on intestinal ion transport modulation Emanuel Fernando Pinto Guedes Lopes Matias (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2019/05 Preanalytical conditions for lipid determination: A survey on the awareness of medical students and clinicians Diogo de Sousa Seabra (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2018/04 Clinical Management of Anti-TNF-alpha-induced Psoriasis or Psoriasiform Lesions in Inflammatory Bowel Disease Patients: a Systematic Review Francisco Jorge Nunes de Melo (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2012/12 Role of innate immunity receptors toll-like 2 and 4 in gastrointestinal diseases
Thesis Member
Pedro Filipe Vieira Pimentel Nunes (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2012/11 Butyrate transport in the colon epitheliym and its repercussion in colorectal cancer
Thesis Member
Pedro Filipe Fernandes Gonçalves (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
2012/05 A influência da nicotina na Colite Ulcerosa
President of the jury
Cristina Raquel Vieira Mendes (Master)
Universidade do Porto Faculdade de Medicina, Portugal

Association member

Society Organization name Role
2023 - Current President-Elect of the European Crohn's and Colitis Organization (ECCO) President-Elect

Committee member

Activity description
Role
Institution / Organization
2016 - Current Clinical Trial National Coordinator - FORTIFY: A Multicenter, Randomized, Double-Blind, Placebo- Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Crohn’s Disease Who Responded to Induction Treatment in M16-006 or M15- 991; or Completed M15-989 (EudraCT 2016-003191-50)
Coordinator
2016 - Current Clinical Trial National Coordinator - MOTIVATE: A Multicenter, Randomized, Double-Blind, Placebo- Controlled Induction Study to Assess the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severe Active Crohn’s Disease Who Failed Prior Biologic Treatment (EudraCT 2016-003190-17)
Coordinator
2016 - Current Clinical Trial National Coordinator - ADVANCE: A Multicenter, Randomized, Double-Blind, Placebo- Controlled Induction Study of the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severe Active Crohn’s Disease (EudraCT 2016-003123-32)
Coordinator
2016 - Current Clinical Trial National Coordinator - STARDUST: Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn’s Disease Patients Treated with Ustecinumab (NCT: 2016-002918-43)
Coordinator
2014 - Current Clinical Trial National Coordinator - EVOLUTION: An open label, single group assignment design study to correlate soluble ST2 with clinical, endoscopic and histological activity in moderate to severe Ulcerative Colitis patients under golimumab (EudraCT 2014–003262–25)
Coordinator
2009 - Current Clinical Trial Promoter - Histological and Endoscopic Evaluation of Remission Induced by Infliximab in Moderately to Severely Active Ulcerative Colitis Patients (HERICA; EudraCT Nr: 2009-013890-16)
Coordinator
2011 - 2015 Clinical Trial National Coordinator - OPERA study: PF-00547659 is Safe and Improves Disease Symptoms in Patients with Crohn's Disease (NCT01276509)
Coordinator
2008 - 2015 Clinical Trial National Coordinator - An Open Randomized Multicenter Clinical Investigation to Compare the Efficacy and Safety of Prednisone plus Adacolumn® GMA Apheresis versus Prednisone Alone in the Treatment of Patients with Mild or Moderately Active Steroid Dependent Ulcerative Colitis (NCT00702611)
Coordinator